BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology;38:1449-57. [DOI: 10.1016/j.hep.2003.09.022] [Cited by in Crossref: 1132] [Cited by in F6Publishing: 1230] [Article Influence: 62.9] [Reference Citation Analysis]
Number Citing Articles
1 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-409, v-vi. [PMID: 25633908 DOI: 10.3310/hta19090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 14.0] [Reference Citation Analysis]
2 Friedrich-Rust M, Wunder K, Kriener S, Sotoudeh F, Richter S, Bojunga J, Herrmann E, Poynard T, Dietrich CF, Vermehren J, Zeuzem S, Sarrazin C. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009;252:595-604. [PMID: 19703889 DOI: 10.1148/radiol.2523081928] [Cited by in Crossref: 434] [Cited by in F6Publishing: 414] [Article Influence: 36.2] [Reference Citation Analysis]
3 Laharie D, Seneschal J, Schaeverbeke T, Doutre M, Longy-boursier M, Pellegrin J, Chabrun E, Villars S, Zerbib F, de Lédinghen V. Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study. Journal of Hepatology 2010;53:1035-40. [DOI: 10.1016/j.jhep.2010.04.043] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
4 Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, Thabut D, Morra R, Messous D, Charlotte F, Imbert-Bismut F, Bonnefont-Rousselot D, Moussalli J, Ratziu V, Poynard T. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS One 2008;3:e2573. [PMID: 18596917 DOI: 10.1371/journal.pone.0002573] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
5 Delić D, Nesić Z, Prostran M, Boricić I, Tomanović N, Cutović M, Dokić L, Simonović J, Svirtlih N. Histopathology of chronic hepatitis C in relation to virus genotype. Vojnosanit Pregl. 2006;63:819-825. [PMID: 17039894 DOI: 10.2298/VSP0609819D] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Czaja AJ, Carpenter HA. Optimizing Diagnosis From the Medical Liver Biopsy. Clinical Gastroenterology and Hepatology 2007;5:898-907. [DOI: 10.1016/j.cgh.2007.05.031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
7 Le TH, Caldwell SH, Redick JA, Sheppard BL, Davis CA, Arseneau KO, Iezzoni JC, Hespenheide EE, Al-Osaimi A, Peterson TC. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology. 2004;39:1423-1429. [PMID: 15122772 DOI: 10.1002/hep.20202] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
8 Tapper EB, Loomba R. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nat Rev Gastroenterol Hepatol 2018;15:274-82. [PMID: 29463906 DOI: 10.1038/nrgastro.2018.10] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 19.7] [Reference Citation Analysis]
9 Dewitt J, McGreevy K, Cummings O, Sherman S, Leblanc JK, McHenry L, Al-Haddad M, Chalasani N. Initial experience with EUS-guided Tru-cut biopsy of benign liver disease. Gastrointest Endosc. 2009;69:535-542. [PMID: 19231495 DOI: 10.1016/j.gie.2008.09.056] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
10 Connoley D, Patel PJ, Hogan B, Tanwar S, Rhodes F, Parkes J, Burt A, Watkins J, Sievert W, Rosenberg W. The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study. BMC Gastroenterol 2021;21:268. [PMID: 34182924 DOI: 10.1186/s12876-021-01795-5] [Reference Citation Analysis]
11 Guido M, Mangia A, Faa G. Chronic viral hepatitis: The histology report. Digestive and Liver Disease 2011;43:S331-43. [DOI: 10.1016/s1590-8658(11)60589-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
12 Xu H, Kong W, Liu L, Chi X, Wang X, Wu R, Gao X, Wang H, Qu L, Qi Y, Pan Y, Niu J. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C. BMC Gastroenterol 2017;17:62. [PMID: 28486931 DOI: 10.1186/s12876-017-0618-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
13 Abdel-Wahab M, Abdel-Khalek EE, El-Gilany AH, Yassen AM, Al-Shobari M, Shiha U, Ali M, Sadani M, Salah T, Sultan AM, Elghawalby AN, Elmorshedi M, Al-Refaey AK, Abdalla U. Predictors of hepatitis C virus recurrence after living donor liver transplantation: Mansoura experience. Arab J Gastroenterol 2017;18:151-5. [PMID: 28958486 DOI: 10.1016/j.ajg.2017.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Toshima T, Shirabe K, Takeishi K, Motomura T, Mano Y, Uchiyama H, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011;46:705-711. [PMID: 21264479 DOI: 10.1007/s00535-010-0365-7] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 8.6] [Reference Citation Analysis]
15 Chung JH, Ahn HS, Kim SG, Lee YN, Kim YS, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS. The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis. Clin Mol Hepatol. 2013;19:156-164. [PMID: 23837140 DOI: 10.3350/cmh.2013.19.2.156] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
16 Attia D, Pischke S, Negm AA, Rifai K, Manns MP, Gebel MJ, Lankisch TO, Potthoff A. Changes in liver stiffness using acoustic radiation force impulse imaging in patients with obstructive cholestasis and cholangitis. Dig Liver Dis. 2014;46:625-631. [PMID: 24666759 DOI: 10.1016/j.dld.2014.02.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
17 Erman A, Sathya A, Nam A, Bielecki JM, Feld JJ, Thein HH, Wong WWL, Grootendorst P, Krahn MD. Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysis. J Viral Hepat 2018;25:502-13. [PMID: 29239068 DOI: 10.1111/jvh.12846] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
18 Zheng YX, Ma SJ, Lu MH. Diagnostic Estimation of Noninvasive Tests for Hepatic Fibrosis in Chronic Hepatitis B Patients Without a Gold Standard. Hepat Mon 2016;16:e31983. [PMID: 27148383 DOI: 10.5812/hepatmon.31983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Kawano T, Murata M, Hyodo F, Eto H, Kosem N, Nakata R, Hamano N, Piao JS, Narahara S, Akahoshi T, Hashizume M. Noninvasive mapping of the redox status of dimethylnitrosamine-induced hepatic fibrosis using in vivo dynamic nuclear polarization-magnetic resonance imaging. Sci Rep 2016;6:32604. [PMID: 27587186 DOI: 10.1038/srep32604] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
20 Pang JX, Zimmer S, Niu S, Crotty P, Tracey J, Pradhan F, Shaheen AA, Coffin CS, Heitman SJ, Kaplan GG, Swain MG, Myers RP. Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. PLoS One 2014;9:e95776. [PMID: 24755824 DOI: 10.1371/journal.pone.0095776] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 9.7] [Reference Citation Analysis]
21 Nguyen-Khac E, Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan). Eur J Gastroenterol Hepatol. 2006;18:1321-1325. [PMID: 17099382 DOI: 10.1097/01.meg.0000243884.55562.37] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
22 Li C, Dhyani M, Bhan AK, Grajo JR, Pratt DS, Gee MS, Samir AE. Diagnostic Performance of Shear Wave Elastography in Patients With Autoimmune Liver Disease. J Ultrasound Med. 2018;. [PMID: 29761535 DOI: 10.1002/jum.14668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Guido M, Colloredo G, Fassan M, Rugge M. Clinical practice and ideal liver biopsy sampling standards:Not just a matter of centimeters. Journal of Hepatology 2006;44:823-4. [DOI: 10.1016/j.jhep.2006.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Huwart L, van Beers B. MR elastography. Gastroentérologie Clinique et Biologique 2008;32:68-72. [DOI: 10.1016/s0399-8320(08)73995-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
25 Grünhage F, Wasmuth JC, Herkenrath S, Vidovic N, Goldmann G, Rockstroh J, Lammert F, Oldenburg J, Sauerbruch T, Spengler U. Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART. Eur J Med Res 2010;15:139-44. [PMID: 20554494 DOI: 10.1186/2047-783x-15-4-139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
26 Suk KT, Kim DY, Sohn KM, Kim DJ. Biomarkers of liver fibrosis. Adv Clin Chem 2013;62:33-122. [PMID: 24772665 DOI: 10.1016/b978-0-12-800096-0.00002-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Qing S, Ji D, Li B, Li F, Wang Y, Niu X, Ling B, Meng Y, Lau G, Chen G. Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus. Ann Saudi Med 2015;35:293-7. [PMID: 26497709 DOI: 10.5144/0256-4947.2015.293] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
28 Kohlhaas A, Durango E, Millonig G, Bastard C, Sandrin L, Golriz M, Mehrabi A, Büchler MW, Seitz HK, Mueller S. Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites. Hepat Med. 2012;4:11-18. [PMID: 24367229 DOI: 10.2147/hmer.s30256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
29 Sánchez-Conde M, Montes Ramírez ML, Bellón Cano JM, Caminoa A, Alvarez Rodríguez F, González Garcia J, Miralles Martín P, Bernardino de la Serna I, Bernardo de Quirós JC, Arribas López JR, Cosín Ochaíta J, Pascual Pareja JF, Alvarez E, Berenguer JB. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. J Viral Hepat 2011;18:e278-83. [PMID: 21129129 DOI: 10.1111/j.1365-2893.2010.01407.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
30 Adhoute X, Foucher J, Laharie D, Terrebonne E, Vergniol J, Castéra L, Lovato B, Chanteloup E, Merrouche W, Couzigou P. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol. 2008;32:180-187. [PMID: 18496894 DOI: 10.1016/j.gcb.2007.12.021] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
31 Vuppalanchi R, Unalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, Tonascia J, Chalasani N. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol 2009;7:481-6. [PMID: 19162235 DOI: 10.1016/j.cgh.2008.12.015] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 8.5] [Reference Citation Analysis]
32 R. Wanless I, M. Crawford J. Cirrhosis. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1115-45. [DOI: 10.1016/b978-141604059-0.50045-x] [Cited by in Crossref: 9] [Article Influence: 0.8] [Reference Citation Analysis]
33 Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011;34:729-749. [PMID: 22025886 DOI: 10.1002/jmri.22775] [Cited by in Crossref: 52] [Cited by in F6Publishing: 266] [Article Influence: 5.2] [Reference Citation Analysis]
34 Trzepizur W, Boursier J, Le Vaillant M, Ducluzeau PH, Dubois S, Henni S, Abraham P, Aubé C, Calès P, Gagnadoux F; on the behalf of the METABOL group. Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities. Eur Respir J 2018;51:1800601. [PMID: 29880653 DOI: 10.1183/13993003.00601-2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
35 Yamaguchi T, Hachiya H. Proposal of a parametric imaging method for quantitative diagnosis of liver fibrosis. J Med Ultrasonics 2010;37:155-66. [DOI: 10.1007/s10396-010-0270-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
36 Erdogan S, Dogan HO, Sezer S, Uysal S, Ozhamam E, Kayacetin S, Koca Y. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients. Scand J Clin Lab Invest. 2013;73:300-308. [PMID: 23514016 DOI: 10.3109/00365513.2013.773592] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
37 Manousou P, Burroughs AK, Tsochatzis E, Isgro G, Hall A, Green A, Calvaruso V, Ma GL, Gale J, Burgess G. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation. J Hepatol. 2013;58:962-968. [PMID: 23262247 DOI: 10.1016/j.jhep.2012.12.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
38 Nitta Y, Kawabe N, Hashimoto S, Harata M, Komura N, Kobayashi K, Arima Y, Shimazaki H, Nakano T, Murao M. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res. 2009;39:675-684. [PMID: 19261000 DOI: 10.1111/j.1872-034x.2009.00500.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
39 Vergara S, Macías J, Rivero A, Gutiérrez-Valencia A, González-Serrano M, Merino D, Ríos MJ, García-García JA, Camacho A, López-Cortés L, Ruiz J, de la Torre J, Viciana P, Pineda JA; Grupo para el Estudio de las Hepatitis Viricas de la SAEI. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007;45:969-74. [PMID: 17879910 DOI: 10.1086/521857] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 10.1] [Reference Citation Analysis]
40 Bansal MB, Friedman SL. Hepatic Fibrogenesis. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 94-102. [DOI: 10.1002/9781444341294.ch6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Park GJ, Katelaris PH, Jones DB, Seow F, Lin BPC, Le Couteur DG, Ngu MC. The 13C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther 2005;22:395-403. [DOI: 10.1111/j.1365-2036.2005.02623.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
42 Azer SA, Azer S. Bibliometric analysis of the top-cited gastroenterology and hepatology articles. BMJ Open 2016;6:e009889. [PMID: 26857105 DOI: 10.1136/bmjopen-2015-009889] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
43 Dong J, Xu X, Ke M, Xiang J, Liu W, Liu X, Wang B, Zhang X, Lv Y. The FIB-4 score predicts postoperative short-term outcomes of hepatocellular carcinoma fulfilling the milan criteria. European Journal of Surgical Oncology (EJSO) 2016;42:722-7. [DOI: 10.1016/j.ejso.2016.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
44 Yang L, Ling W, He D, Lu C, Ma L, Tang L, Luo Y, Chen S. Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases. Quant Imaging Med Surg 2021;11:1532-42. [PMID: 33816189 DOI: 10.21037/qims-20-521] [Reference Citation Analysis]
45 Maimone S, Calvaruso V, Pleguezuelo M, Squadrito G, Amaddeo G, Jacobs M, Khanna P, Raimondo G, Dusheiko G. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers. J Viral Hepat. 2009;16:769-774. [PMID: 19709363 DOI: 10.1111/j.1365-2893.2009.01120.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
46 Kohla MAS, Abbasy M, Abozeid M, El-Abd O, Ezzat S, Kohla S, Abdel-Rahman M. Assessment of liver fibrosis with acoustic radiation force impulse imaging versus liver histology in patients with chronic hepatitis C: a pilot study. Eur J Gastroenterol Hepatol 2017;29:951-5. [PMID: 28471822 DOI: 10.1097/MEG.0000000000000903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
47 European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167-185. [PMID: 22436845 DOI: 10.1016/j.jhep.2012.02.010] [Cited by in Crossref: 2167] [Cited by in F6Publishing: 2065] [Article Influence: 240.8] [Reference Citation Analysis]
48 Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience. J Pediatr. 2013;163:1058-64.e2. [PMID: 23759423 DOI: 10.1016/j.jpeds.2013.04.044] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
49 Hall AR, Tsochatzis E, Morris R, Burroughs AK, Dhillon AP. Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers. Histopathology. 2013;62:421-430. [PMID: 23134419 DOI: 10.1111/his.12010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
50 Hu Q, Zhu SY, Kang LK, Wang XY, Lun HM, Xu CM. Non-invasive assessment of liver fibrosis using real-time tissue elastography in patients with chronic hepatitis B. Clin Radiol. 2014;69:194-199. [PMID: 24290780 DOI: 10.1016/j.crad.2013.10.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
51 Razek AA, Abdalla A, Omran E, Fathy A, Zalata K. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol. 2011;78:129-134. [PMID: 19926420 DOI: 10.1016/j.ejrad.2009.10.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
52 Sandrin L, Fournier C, Miette V, Yon S, Hasquenoph J. Fibroscan® : un outil non invasif de mesure de la dureté du foie par élastométrie. ITBM-RBM 2006;27:25-31. [DOI: 10.1016/j.rbmret.2005.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
53 Friedrich-Rust M, Nierhoff J, Lupsor M, Sporea I, Fierbinteanu-Braticevici C, Strobel D, Takahashi H, Yoneda M, Suda T, Zeuzem S, Herrmann E. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012;19:e212-e219. [PMID: 22239521 DOI: 10.1111/j.1365-2893.2011.01537.x] [Cited by in Crossref: 312] [Cited by in F6Publishing: 282] [Article Influence: 31.2] [Reference Citation Analysis]
54 Bourlière M, Pénaranda G, Adhoute X, Oules V, Castellani P. Combining non-invasive methods for assessment of liver fibrosis. Gastroentérologie Clinique et Biologique 2008;32:73-9. [DOI: 10.1016/s0399-8320(08)73996-4] [Cited by in Crossref: 9] [Article Influence: 0.7] [Reference Citation Analysis]
55 Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18:337-357, ix. [PMID: 21094444 DOI: 10.1016/j.mric.2010.08.013] [Cited by in Crossref: 172] [Cited by in F6Publishing: 156] [Article Influence: 17.2] [Reference Citation Analysis]
56 Zhang L, Li QY, Duan YY, Yan GZ, Yang YL, Yang RJ. Artificial neural network aided non-invasive grading evaluation of hepatic fibrosis by duplex ultrasonography. BMC Med Inform Decis Mak 2012;12:55. [PMID: 22716936 DOI: 10.1186/1472-6947-12-55] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
57 Hiroyama S, Rokugawa T, Ito M, Iimori H, Morita I, Maeda H, Fujisawa K, Matsunaga K, Shimosegawa E, Abe K. Quantitative evaluation of hepatic integrin αvβ3 expression by positron emission tomography imaging using 18F-FPP-RGD2 in rats with non-alcoholic steatohepatitis. EJNMMI Res 2020;10:118. [PMID: 33026561 DOI: 10.1186/s13550-020-00704-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Levine RA, Sanderson SO, Ploutz–snyder R, Murray F, Kay E, Hegarty J, Nolan N, Kelleher D, Mcdonald G, O’keane JC, Crowe J. Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D. Clinical Gastroenterology and Hepatology 2006;4:1271-7. [DOI: 10.1016/j.cgh.2006.05.028] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
59 Long MT, Gandhi S, Loomba R. Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Metabolism 2020;111S:154259. [PMID: 32387227 DOI: 10.1016/j.metabol.2020.154259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
60 Huang ZP, Zhang XL, Zeng J, Zheng J, Wang P, Zheng RQ. Study of detection times for liver stiffness evaluation by shear wave elastography. World J Gastroenterol 2014; 20(28): 9578-9584 [PMID: 25071355 DOI: 10.3748/wjg.v20.i28.9578] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
61 Said M. Evaluation of routine biochemical indices and α-fetoprotein versus histology in chronic hepatitis C patients. Arab Journal of Gastroenterology 2009;10:87-91. [DOI: 10.1016/j.ajg.2009.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
62 Ma C, Liu A, Wang Y, Geng X, Hao L, Song Q, Sun B, Wang H, Zhao G. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study. Life Sci. 2014;108:104-108. [PMID: 24881519 DOI: 10.1016/j.lfs.2014.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Halfon P, Bourliere M, Deydier R, Botta-fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-allieri A, Rotily M, Sattonet C, Benderitter T, Paul MCS, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D. Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study. Am J Gastroenterology 2006;101:547-55. [DOI: 10.1111/j.1572-0241.2006.00411.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 6.5] [Reference Citation Analysis]
64 Liu J, Hu HH, Lee MH, Korenaga M, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, Mizokami M, Chen CJ, Yang HI. Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients. Sci Rep. 2017;7:14352. [PMID: 29085039 DOI: 10.1038/s41598-017-14747-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
65 Castéra L, Bernard PH, Le Bail B, Foucher J, Trimoulet P, Merrouche W, Couzigou P, de Lédinghen V. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther. 2011;33:455-465. [PMID: 21235598 DOI: 10.1111/j.1365-2036.2010.04547.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
66 Baba M, Furuya K, Bandou H, Kasai K, Sadaoka K. Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study. BMC Gastroenterol. 2011;11:70. [PMID: 21669003 DOI: 10.1186/1471-230x-11-70] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
67 Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376-82. [DOI: 10.1002/hep.20717] [Cited by in Crossref: 229] [Cited by in F6Publishing: 230] [Article Influence: 14.3] [Reference Citation Analysis]
68 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(15): 4300-4315 [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
69 Lutz P, Wasmuth JC, Nischalke HD, Vidovic N, Grünhage F, Lammert F, Oldenburg J, Rockstroh JK, Sauerbruch T, Spengler U. Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene. Eur J Med Res. 2011;16:335-341. [PMID: 21813376 DOI: 10.1186/2047-783x-16-8-335] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
70 Chin JL, Pavlides M, Moolla A, Ryan JD. Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? Front Pharmacol. 2016;7:159. [PMID: 27378924 DOI: 10.3389/fphar.2016.00159] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
71 Palmer T, Georgiades I, Treanor D, Wright A, Shah M, Khosla R, Wyatt JI. Improved tissue sections for medical liver biopsies: a comparison of 16 vs 18 g biopsy needles using digital pathology. J Clin Pathol 2014;67:415-9. [DOI: 10.1136/jclinpath-2013-201954] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
72 Calès P, Chaigneau J, Hunault G, Michalak S, Cavaro-Menard C, Fasquel JB, Bertrais S, Rousselet MC. Automated morphometry provides accurate and reproducible virtual staging of liver fibrosis in chronic hepatitis C. J Pathol Inform 2015;6:20. [PMID: 26110088 DOI: 10.4103/2153-3539.157782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
73 Bracht T, Mölleken C, Ahrens M, Poschmann G, Schlosser A, Eisenacher M, Stühler K, Meyer HE, Schmiegel WH, Holmskov U, Sorensen GL, Sitek B. Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients. J Transl Med 2016;14:201. [PMID: 27378383 DOI: 10.1186/s12967-016-0952-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
74 Aithal GP. Hepatotoxicity Related to Methotrexate. Drug-Induced Liver Disease. Elsevier; 2013. pp. 593-604. [DOI: 10.1016/b978-0-12-387817-5.00032-7] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
75 Suk KT, Kim DJ. Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol 2015; 7(3): 607-615 [PMID: 25848485 DOI: 10.4254/wjh.v7.i3.607] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
76 Wang TH, Chen TC, Teng X, Liang KH, Yeh CT. Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy. Sci Rep. 2015;5:12962. [PMID: 26260921 DOI: 10.1038/srep12962] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
77 Kelleher TB, Afdhal N. Assessment of liver fibrosis in co-infected patients. J Hepatol 2006;44:S126-31. [PMID: 16352364 DOI: 10.1016/j.jhep.2005.11.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
78 Longerich T, Flechtenmacher C, Schirmacher P. [Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases]. Pathologe 2008;29:15-26. [PMID: 18210114 DOI: 10.1007/s00292-007-0963-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
79 Yoshioka K, Hashimoto S. Can non-invasive assessment of liver fibrosis replace liver biopsy? Hepatol Res 2012;42:233-40. [PMID: 22151829 DOI: 10.1111/j.1872-034X.2011.00928.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
80 Mangus RS, O'Connor MG, Tector AJ, Lim JD, Vianna RM. Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. J Pediatr Surg 2010;45:1266-73. [PMID: 20620330 DOI: 10.1016/j.jpedsurg.2010.02.098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
81 Zhang DK, Chen M, Liu Y, Wang RF, Liu LP, Li M. Acoustic radiation force impulse elastography for non-invasive assessment of disease stage in patients with primary biliary cirrhosis: A preliminary study. Clin Radiol. 2014;69:836-840. [PMID: 24837697 DOI: 10.1016/j.crad.2014.03.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
82 Ahn SH, Chan HL, Chen PJ, Cheng J, Goenka MK, Hou J, Lim SG, Omata M, Piratvisuth T, Xie Q, Yim HJ, Yuen MF; APPROACH Working Group. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions. Hepatol Int. 2010;4:386-395. [PMID: 20305758 DOI: 10.1007/s12072-010-9163-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
83 Kinner S, Reeder SB, Yokoo T. Quantitative Imaging Biomarkers of NAFLD. Dig Dis Sci. 2016;61:1337-1347. [PMID: 26848588 DOI: 10.1007/s10620-016-4037-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
84 Jin N, Deng J, Chadashvili T, Zhang Y, Guo Y, Zhang Z, Yang GY, Omary RA, Larson AC. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis. Radiology. 2010;254:129-137. [PMID: 20032147 DOI: 10.1148/radiol.09090410] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
85 Blasco A, Forns X, Carrión JA, García-Pagán JC, Gilabert R, Rimola A, Miquel R, Bruguera M, García-Valdecasas JC, Bosch J. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology. 2006;43:492-499. [PMID: 16496308 DOI: 10.1002/hep.21090] [Cited by in Crossref: 220] [Cited by in F6Publishing: 199] [Article Influence: 14.7] [Reference Citation Analysis]
86 Karanjia RN, Crossey MME, Cox IJ, Fye HKS, Njie R, Goldin RD, Taylor-Robinson SD. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol 2016; 22(45): 9880-9897 [PMID: 28018096 DOI: 10.3748/wjg.v22.i45.9880] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
87 Vergniol J, Foucher J, Castéra L, Bernard PH, Tournan R, Terrebonne E, Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Changes of non-invasive markers and FibroScan values during HCV treatment. J Viral Hepat. 2009;16:132-140. [PMID: 19175875 DOI: 10.1111/j.1365-2893.2008.01055.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 6.0] [Reference Citation Analysis]
88 Schachter JL, Patel M, Horton SR, Mike Devane A, Ewing A, Abrams GA. FibroSURE and elastography poorly predict the severity of liver fibrosis in Fontan-associated liver disease. Congenit Heart Dis 2018;13:764-70. [PMID: 30101472 DOI: 10.1111/chd.12650] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
89 Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, Poynard T. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol. 2006;44:S19-S24. [PMID: 16356583 DOI: 10.1016/j.jhep.2005.11.009] [Cited by in Crossref: 132] [Cited by in F6Publishing: 124] [Article Influence: 8.3] [Reference Citation Analysis]
90 Bedossa P. Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential. Liver Int. 2018;38 Suppl 1:64-66. [PMID: 29427497 DOI: 10.1111/liv.13653] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
91 Veidal SS, Karsdal MA, Nawrocki A, Larsen MR, Dai Y, Zheng Q, Hägglund P, Vainer B, Skjøt-Arkil H, Leeming DJ. Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis. Fibrogenesis Tissue Repair 2011;4:22. [PMID: 21970406 DOI: 10.1186/1755-1536-4-22] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 8.0] [Reference Citation Analysis]
92 Chouhan MD, Fitzke HE, Bainbridge A, Atkinson D, Halligan S, Davies N, Lythgoe MF, Mookerjee RP, Menys A, Taylor SA. Cardiac-induced liver deformation as a measure of liver stiffness using dynamic imaging without magnetization tagging-preclinical proof-of-concept, clinical translation, reproducibility and feasibility in patients with cirrhosis. Abdom Radiol (NY) 2021. [PMID: 34148103 DOI: 10.1007/s00261-021-03168-8] [Reference Citation Analysis]
93 Di Maria MV, Silverman L, Younoszai AK, Meyers ML, Capocelli KE, Narkewicz MR. Acoustic radiation force impulse of the liver after Fontan operation: Correlation with cardiopulmonary exercise test. Congenit Heart Dis 2018;13:444-9. [PMID: 29473337 DOI: 10.1111/chd.12594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
94 Palaniyappan N, Cox E, Bradley C, Scott R, Austin A, O'Neill R, Ramjas G, Travis S, White H, Singh R, Thurley P, Guha IN, Francis S, Aithal GP. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol. 2016;65:1131-1139. [PMID: 27475617 DOI: 10.1016/j.jhep.2016.07.021] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
95 Beckmann MG, Bahr MJ, Hadem J, Bredt M, Wedemeyer H, Schneider AS, Kubicka S, Manns MP, Strassburg CP, Wedemeyer J. Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy. Gastroenterol Res Pract 2009;2009:947014. [PMID: 19920868 DOI: 10.1155/2009/947014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
96 Schiavon LL, Narciso-Schiavon JL, Carvalho-Filho RJ. Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol 2014; 20(11): 2854-2866 [PMID: 24659877 DOI: 10.3748/wjg.v20.i11.2854] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
97 Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Shibata A, Asada W, Kawabe N, Hashimoto S, Murao M, Nakano T, Shimazaki H, Kan T, Nakaoka K, Takagawa Y, Ohki M, Kurashita T, Takamura T, Yoshioka K. Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C. World J Gastroenterol 2015; 21(35): 10215-10223 [PMID: 26401087 DOI: 10.3748/wjg.v21.i35.10215] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
98 Lim AK, Patel N, Eckersley RJ, Cobbold JF, Crossey MM, Cosgrove DO, Goldin RD, Thomas HC, Taylor-Robinson SD. Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C. J Viral Hepat 2010;17:778-83. [PMID: 20002308 DOI: 10.1111/j.1365-2893.2009.01234.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
99 Ingiliz P, Chhay KP, Munteanu M, Lebray P, Ngo Y, Roulot D, Benhamou Y, Thabut D, Ratziu V, Poynard T. Applicability and variability of liver stiffness measurements according to probe position. World J Gastroenterol 2009; 15(27): 3398-3404 [PMID: 19610141 DOI: 10.3748/wjg.15.3398] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
100 Sporea I, Bota S, Peck-Radosavljevic M, Sirli R, Tanaka H, Iijima H, Badea R, Lupsor M, Fierbinteanu-Braticevici C, Petrisor A. Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol. 2012;81:4112-4118. [PMID: 23000186 DOI: 10.1016/j.ejrad.2012.08.018] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 12.8] [Reference Citation Analysis]
101 Tai DC, Tan N, Xu S, Kang CH, Chia SM, Cheng CL, Wee A, Wei CL, Raja AM, Xiao G, Chang S, Rajapakse JC, So PT, Tang HH, Chen CS, Yu H. Fibro-C-Index: comprehensive, morphology-based quantification of liver fibrosis using second harmonic generation and two-photon microscopy. J Biomed Opt 2009;14:044013. [PMID: 19725725 DOI: 10.1117/1.3183811] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
102 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci 2016;53:396-408. [PMID: 27187575 DOI: 10.1080/10408363.2016.1190683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
103 Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 96] [Article Influence: 16.7] [Reference Citation Analysis]
104 Kishanifarahani Z, Ahadi M, Kazeminejad B, Mollasharifi T, Saber Afsharian M, Sadeghi A, Bidari F, Jamali E, Hasanzadeh N, Movafagh A, Dehghan A, Moradi A, Moradi A. Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals. Iran J Pathol 2019;14:243-7. [PMID: 31583002 DOI: 10.30699/ijp.2019.99566.1985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 de Lédinghen V, Vergniol J, Barthe C, Foucher J, Chermak F, Le Bail B, Merrouche W, Bernard PH. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther 2013;37:979-88. [PMID: 23557139 DOI: 10.1111/apt.12307] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 9.1] [Reference Citation Analysis]
106 Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology. 2017;66:1486-1501. [PMID: 28586172 DOI: 10.1002/hep.29302] [Cited by in Crossref: 272] [Cited by in F6Publishing: 247] [Article Influence: 68.0] [Reference Citation Analysis]
107 Byenfeldt M, Elvin A, Fransson P. On Patient Related Factors and Their Impact on Ultrasound-Based Shear Wave Elastography of the Liver. Ultrasound Med Biol 2018;44:1606-15. [PMID: 29735314 DOI: 10.1016/j.ultrasmedbio.2018.03.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
108 Malik R, Afdhal N. Stiffness and Impedance: The New Liver Biomarkers. Clinical Gastroenterology and Hepatology 2007;5:1144-6. [DOI: 10.1016/j.cgh.2007.07.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
109 Falcon-perez JM, Royo F. Circulating RNA: looking at the liver through a frosted glass. Biomarkers 2015;20:339-54. [DOI: 10.3109/1354750x.2015.1101785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
110 Friedenberg MA, Miller L, Chung CY, Fleszler F, Banson FL, Thomas R, Swartz KP, Friedenberg FK. Simplified method of hepatic fibrosis quantification: design of a new morphometric analysis application. Liver Int. 2005;25:1156-1161. [PMID: 16343066 DOI: 10.1111/j.1478-3231.2005.01161.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
111 Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, Goto T, Yoshida H, Kanai F, Sugioka Y, Ikeda H, Shiina S, Kawabe T, Omata M. Comparison of liver biopsy and transient elastography based on clinical relevance. Can J Gastroenterol 2008;22:753-7. [PMID: 18818788 DOI: 10.1155/2008/306726] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
112 Wáng YXJ, Wang X, Wu P, Wang Y, Chen W, Chen H, Li J. Topics on quantitative liver magnetic resonance imaging. Quant Imaging Med Surg 2019;9:1840-90. [PMID: 31867237 DOI: 10.21037/qims.2019.09.18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
113 Pavlides M, Banerjee R, Tunnicliffe EM, Kelly C, Collier J, Wang LM, Fleming KA, Cobbold JF, Robson MD, Neubauer S, Barnes E. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int. 2017;37:1065-1073. [PMID: 27778429 DOI: 10.1111/liv.13284] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 22.8] [Reference Citation Analysis]
114 Li X, Jin Q, Zhang H, Jing X, Ding Z, Zhou H, Zhang Z, Yan D, Li D, Gao P, Niu J. Changes in liver stiffness and its associated factors during oral antiviral therapy in Chinese patients with chronic hepatitis B. Exp Ther Med 2017;13:1169-75. [PMID: 28450959 DOI: 10.3892/etm.2017.4065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
115 Kutty SS, Peng Q, Danford DA, Fletcher SE, Perry D, Talmon GA, Scott C, Kugler JD, Duncan KF, Quiros-Tejeira RE, Kutty S; Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study (LADS) Group. Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: a vascular Doppler and elastography study. Hepatology. 2014;59:251-260. [PMID: 23913702 DOI: 10.1002/hep.26631] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 9.9] [Reference Citation Analysis]
116 Chandarana H, Do RK, Mussi TC, Jensen JH, Hajdu CH, Babb JS, Taouli B. The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis. AJR Am J Roentgenol. 2012;199:803-808. [PMID: 22997371 DOI: 10.2214/ajr.11.7541] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
117 Carrión JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006;12:1791-8. [DOI: 10.1002/lt.20857] [Cited by in Crossref: 300] [Cited by in F6Publishing: 274] [Article Influence: 20.0] [Reference Citation Analysis]
118 Yan LB, Zhang QB, Zhu X, He M, Tang H. Serum S100 calcium binding protein A4 improves the diagnostic accuracy of transient elastography for assessing liver fibrosis in hepatitis B. Clin Res Hepatol Gastroenterol. 2018;42:64-71. [PMID: 28688902 DOI: 10.1016/j.clinre.2017.05.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
119 Ferraioli G, Tinelli C, Dal Bello B, Zicchetti M, Filice G, Filice C; Liver Fibrosis Study Group. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012;56:2125-2133. [PMID: 22767302 DOI: 10.1002/hep.25936] [Cited by in Crossref: 417] [Cited by in F6Publishing: 363] [Article Influence: 46.3] [Reference Citation Analysis]
120 Vergara M, Bejarano G, Dalmau B, Gil M, Miquel M, Sanchez-Delgado J, Casas M, Puig J, Martinez-Bauer E, Dosal A, Lopez M, Moreno L, Valero O, Bella MR, Calvet X. Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2015;27:826-33. [PMID: 26043289 DOI: 10.1097/MEG.0000000000000346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
121 Nallagangula KS, Lakshmaiah V, Muninarayana C, Deepa KV, Shashidhar KN. A proteomic approach of biomarker candidate discovery for alcoholic liver cirrhosis. J Circ Biomark 2018;7:1849454418788417. [PMID: 30034555 DOI: 10.1177/1849454418788417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
122 Tapper EB, Challies T, Nasser I, Afdhal NH, Lai M. The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2016;111:677-684. [PMID: 26977758 DOI: 10.1038/ajg.2016.49] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 15.4] [Reference Citation Analysis]
123 Li C, Zhang C, Li J, Huo H, Song D. Diagnostic Accuracy of Real-Time Shear Wave Elastography for Staging of Liver Fibrosis: A Meta-Analysis. Med Sci Monit 2016;22:1349-59. [PMID: 27102449 DOI: 10.12659/msm.895662] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 6.6] [Reference Citation Analysis]
124 Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020;2:100067. [PMID: 32118201 DOI: 10.1016/j.jhepr.2020.100067] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 47.0] [Reference Citation Analysis]
125 Cheung KJ, Tilleman K, Deforce D, Colle I, Moreno C, Gustot T, Van Vlierberghe H. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2011;23:701-710. [PMID: 21623191 DOI: 10.1097/meg.0b013e3283471b74] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
126 Maybury C, Samarasekera E, Douiri A, Barker J, Smith C. Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis. Br J Dermatol 2014;170:1237-47. [DOI: 10.1111/bjd.12905] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
127 Myers RP, Pomier-layrargues G, Kirsch R, Pollett A, Duarte-rojo A, Wong D, Beaton M, Levstik M, Crotty P, Elkashab M. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;55:199-208. [DOI: 10.1002/hep.24624] [Cited by in Crossref: 318] [Cited by in F6Publishing: 295] [Article Influence: 31.8] [Reference Citation Analysis]
128 Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging. 2013;37:544-555. [PMID: 23423795 DOI: 10.1002/jmri.23731] [Cited by in Crossref: 354] [Cited by in F6Publishing: 320] [Article Influence: 44.3] [Reference Citation Analysis]
129 Manka P, Zeller A, Syn W. Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities. Drugs 2019;79:903-27. [DOI: 10.1007/s40265-019-01126-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
130 Abd El Rihim AY, Omar RF, Fathalah W, El Attar I, Hafez HA, Ibrahim W. Role of fibroscan and APRI in detection of liver fibrosis: a systematic review and meta-analysis. Arab J Gastroenterol. 2013;14:44-50. [PMID: 23820499 DOI: 10.1016/j.ajg.2013.05.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
131 Friedman SL, Bansal MB. Reversal of hepatic fibrosis — Fact or fantasy? Hepatology 2006;43:S82-8. [DOI: 10.1002/hep.20974] [Cited by in Crossref: 267] [Cited by in F6Publishing: 262] [Article Influence: 17.8] [Reference Citation Analysis]
132 Trovato FM, Tognarelli JM, Crossey MM, Catalano D, Taylor-Robinson SD, Trovato GM. Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. World J Hepatol 2015; 7(26): 2664-2675 [PMID: 26609343 DOI: 10.4254/wjh.v7.i26.2664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
133 Cai C, Lin Y, Yu C. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol 2019;2019:2096161. [PMID: 31531307 DOI: 10.1155/2019/2096161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
134 De Nicola S, Aghemo A, Rumi MG, Colombo M. HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C. J Hepatol 2009;51:964-6. [PMID: 19775770 DOI: 10.1016/j.jhep.2009.08.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
135 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
136 Capanni M, Lorefice E, Benini MC, Biagini MR, Tozzi A, Salvadori E, Colagrande S, Surrenti C, Milani S. Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. J Chemother 2008;20:380-4. [PMID: 18606596 DOI: 10.1179/joc.2008.20.3.380] [Reference Citation Analysis]
137 Bansal R, Nagórniewicz B, Prakash J. Clinical Advancements in the Targeted Therapies against Liver Fibrosis. Mediators Inflamm 2016;2016:7629724. [PMID: 27999454 DOI: 10.1155/2016/7629724] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]
138 Kim JH, Yim HJ, Kim SY, Ahn JH, Jung YK, Joo MK, Kim SH, Kim JH, Seo YS, Yeon JE, Lee HS, Um SH, Lee SW, Byun KS, Choi JH, Ryu HS. [Changes in liver stiffness after acute or chronic liver injury due to viral hepatitis--does fibrosis exist after recovery from acute viral hepatitis?]. Korean J Gastroenterol 2009;54:155-61. [PMID: 19844151 DOI: 10.4166/kjg.2009.54.3.155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
139 Kumar R, Teo EK, How CH, Wong TY, Ang TL. A practical clinical approach to liver fibrosis. Singapore Med J 2018;59:628-33. [PMID: 30631885 DOI: 10.11622/smedj.2018145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
140 Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007; 13(4): 525-531 [PMID: 17278217 DOI: 10.3748/wjg.v13.i4.525] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 88] [Article Influence: 7.0] [Reference Citation Analysis]
141 Lee HS, Shun CT, Chiou LL, Chen CH, Huang GT, Sheu JC. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. J Gastroenterol Hepatol. 2005;20:1109-1114. [PMID: 15955222 DOI: 10.1111/j.1440-1746.2005.03901.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
142 Forsgren MF, Norén B, Kihlberg J, Dahlqvist Leinhard O, Kechagias S, Lundberg P. Comparing hepatic 2D and 3D magnetic resonance elastography methods in a clinical setting - Initial experiences. Eur J Radiol Open 2015;2:66-70. [PMID: 26937438 DOI: 10.1016/j.ejro.2015.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
143 Arora A, Sharma P. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease. J Clin Exp Hepatol. 2012;2:145-155. [PMID: 25755423 DOI: 10.1016/s0973-6883(12)60103-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
144 Hui AY, Liew CT, Go MY, Chim AM, Chan HL, Leung NW, Sung JJ. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B. Liver Int. 2004;24:611-618. [PMID: 15566512 DOI: 10.1111/j.1478-3231.2004.0957.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
145 Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(24): 7427-7435 [PMID: 26139988 DOI: 10.3748/wjg.v21.i24.7427] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
146 Nguyen-khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly J, Brevet M, Grignon P, Lion S, Le Page L, Dupas J. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Alimentary Pharmacology & Therapeutics 2008;28:1188-98. [DOI: 10.1111/j.1365-2036.2008.03831.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 120] [Article Influence: 11.2] [Reference Citation Analysis]
147 Jeong JY, Sohn JH, Sohn W, Park CH, Kim TY, Jun DW, Kim Y, Jeong WK. Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. Gut Liver. 2017;11:852-859. [PMID: 28651307 DOI: 10.5009/gnl16521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
148 Rawlins SR, Mullen CM, Simon HM, Kim T, Landas SK, Walser MS, Levine RA. Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Gastroenterol Rep (Oxf) 2013;1:51-7. [PMID: 24759667 DOI: 10.1093/gastro/got006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
149 El Saadany S, Soliman H, Ziada DH, Hamisa M, Hefeda M, Selim A, Goraba H. Fibroscan versus liver biopsy in the evaluation of response among the Egyptian HCV infected patients to treatment. The Egyptian Journal of Radiology and Nuclear Medicine 2016;47:1-7. [DOI: 10.1016/j.ejrnm.2015.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
150 Koo JH, Lee MH, Kim SS, Kim DH, Kim IS, Lee KM, Yoo BM, Lee KJ, Kim JH, Cho SW, Cheong JY. Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy. Clinical Biochemistry 2012;45:31-6. [DOI: 10.1016/j.clinbiochem.2011.09.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
151 Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study – ANRS HC02. Journal of Hepatology 2008;48:765-73. [DOI: 10.1016/j.jhep.2008.01.025] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 5.4] [Reference Citation Analysis]
152 Shlomai A, Halfon P, Goldiner I, Zelber-Sagi S, Halpern Z, Oren R, Bruck R. Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C. J Viral Hepat 2013;20:95-102. [PMID: 23301544 DOI: 10.1111/j.1365-2893.2012.01628.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
153 Matas M, Picornell A, Cifuentes C, Payeras A, Bassa A, Homar F, López-Labrador FX, Moya A, Ramon MM, Castro JA. Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients. Infect Genet Evol 2010;10:1252-61. [PMID: 20732459 DOI: 10.1016/j.meegid.2010.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
154 Obrzut M, Atamaniuk V, Obrzut B, Ehman R, Cholewa M, Rzucidło M, Pozaruk A, Gutkowski K. Normative values for magnetic resonance elastography-based liver stiffness in a healthy population. Pol Arch Intern Med 2019;129:321-6. [PMID: 30793705 DOI: 10.20452/pamw.4456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Castera L. Non-invasive diagnosis of steatosis and fibrosis. Diabetes Metab. 2008;34:674-679. [PMID: 19195629 DOI: 10.1016/s1262-3636(08)74603-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
156 Stauber RE, Lackner C. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol 2007; 13(32): 4287-4294 [PMID: 17708599 DOI: 10.3748/wjg.v13.i32.4287] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
157 Foucher J, Reiller B, Jullien V, Léal F, di Cesare ES, Merrouche W, Delile JM, de Lédinghen V. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study. J Viral Hepat 2009;16:121-31. [PMID: 19175876 DOI: 10.1111/j.1365-2893.2008.01050.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
158 European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol. 2009;50:227-242. [PMID: 19054588 DOI: 10.1016/j.jhep.2008.10.001] [Cited by in Crossref: 1092] [Cited by in F6Publishing: 1015] [Article Influence: 84.0] [Reference Citation Analysis]
159 Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA. Histopathologic Variability Between the Right and Left Lobes of the Liver in Morbidly Obese Patients Undergoing Roux-en-Y Bypass. Clinical Gastroenterology and Hepatology 2007;5:1329-32. [DOI: 10.1016/j.cgh.2007.06.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
160 Hall TC, Deakin C, Atwal GS, Singh RK. Adequacy of percutaneous non-targeted liver biopsy under real-time ultrasound guidance when comparing the Biopince and Achieve biopsy needle. BJR 2017;90:20170397. [DOI: 10.1259/bjr.20170397] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
161 Gabr SA, Alghadir AH, Sherif YE, Ghfar AA. Hydroxyproline as a Biomarker in Liver Disease. In: Preedy VR, editor. Biomarkers in Liver Disease. Dordrecht: Springer Netherlands; 2016. pp. 1-21. [DOI: 10.1007/978-94-007-7742-2_26-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
162 Sourianarayanane A, Talluri J, Humar A, Mccullough AJ. Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis: . European Journal of Gastroenterology & Hepatology 2017;29:516-23. [DOI: 10.1097/meg.0000000000000825] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Lu YY, Chen QL, Guan Y, Guo ZZ, Zhang H, Zhang W, Hu YY, Su SB. Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis. Mol Biosyst 2014;10:1117-25. [PMID: 24599568 DOI: 10.1039/c3mb70474b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
164 Ishii N, Harimoto N, Araki K, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Yamanaka T, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Shirabe K. Preoperative Mac‐2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma. Hepatol Res 2019;49:1398-405. [DOI: 10.1111/hepr.13412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
165 Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol. 2005;3:167-174. [PMID: 15704051 DOI: 10.1016/s1542-3565(04)00625-1] [Cited by in Crossref: 97] [Cited by in F6Publishing: 34] [Article Influence: 6.1] [Reference Citation Analysis]
166 Pattullo V, Thein H, Heathcote EJ, Guindi M. Combining semiquantitative measures of fibrosis and qualitative features of parenchymal remodelling to identify fibrosis regression in hepatitis C: a multiple biopsy study: HCV fibrosis regression biopsy study. Histopathology 2012;61:473-87. [DOI: 10.1111/j.1365-2559.2012.04249.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
167 Liu CH, Liang CC, Huang KW, Liu CJ, Chen SI, Lin JW, Hung PH, Tsai HB, Lai MY, Chen PJ. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol. 2011;6:1057-1065. [PMID: 21393486 DOI: 10.2215/cjn.04320510] [Cited by in Crossref: 54] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
168 Cheng KC, Lin WY, Liu CS, Lin CC, Lai HC, Lai SW. Association of different types of liver disease with demographic and clinical factors. Biomedicine (Taipei) 2016;6:16. [PMID: 27518399 DOI: 10.7603/s40681-016-0016-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
169 Zhang TT, Ye SS, Liang J, Bai L. Prognostic value of non-invasive fibrosis indices post-curative resection in hepatitis-B-associated hepatocellular carcinoma patients. Exp Biol Med (Maywood) 2020;245:703-10. [PMID: 32223331 DOI: 10.1177/1535370220914252] [Reference Citation Analysis]
170 Han MAT. Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome. Life (Basel) 2020;10:E198. [PMID: 32933184 DOI: 10.3390/life10090198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
171 Zhang D, Chen M, Wang R, Liu Y, Zhang D, Liu L, Zhou G. Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol. 2015;41:7-14. [PMID: 25308941 DOI: 10.1016/j.ultrasmedbio.2014.07.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
172 Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46:775-782. [PMID: 17321634 DOI: 10.1016/j.jhep.2006.12.013] [Cited by in Crossref: 164] [Cited by in F6Publishing: 148] [Article Influence: 11.7] [Reference Citation Analysis]
173 Facciorusso A, Ramai D, Conti Bellocchi MC, Bernardoni L, Manfrin E, Muscatiello N, Crinò SF. Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. Cancers (Basel) 2021;13:3062. [PMID: 34205389 DOI: 10.3390/cancers13123062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
174 Zhang X, Yang XR, Chen Y, Li HQ, Li RM, Yuan QX, Zhu PP, Huang WX, Peng WJ. Visualising liver fibrosis by phase-contrast X-ray imaging in common bile duct ligated mice. Eur Radiol 2013;23:417-23. [PMID: 22903640 DOI: 10.1007/s00330-012-2630-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
175 Chen C, Fu F, Zhang J, Guo F, Wang M, Zhu S, Shi D, Tian Y. Evaluation of liver fibrosis with a monoexponential model of intravoxel incoherent motion magnetic resonance imaging. Oncotarget 2018;9:24619-26. [PMID: 29872492 DOI: 10.18632/oncotarget.24758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Manousou P, Dhillon AP, Isgro G, Calvaruso V, Luong TV, Tsochatzis E, Xirouchakis E, Kalambokis G, Cross TJ, Rolando N, O'Beirne J, Patch D, Thornburn D, Burroughs AK. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation. Liver Transpl. 2011;17:178-188. [PMID: 21280191 DOI: 10.1002/lt.22209] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
177 Tatsumi C, Kudo M, Ueshima K, Kitai S, Takahashi S, Inoue T, Minami Y, Chung H, Maekawa K, Fujimoto K, Akiko T, Takeshi M. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology. 2008;51 Suppl 1:27-33. [PMID: 18544945 DOI: 10.1159/000122602] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
178 Shiha G, Seif S, Eldesoky A, Elbasiony M, Soliman R, Metwally A, Zalata K, Mikhail N. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C. Hepatol Int 2017;11:286-91. [PMID: 28425016 DOI: 10.1007/s12072-017-9796-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
179 Schnabl B, Farshchi-heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. Nuclear Medicine and Biology 2016;43:179-87. [DOI: 10.1016/j.nucmedbio.2015.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
180 Guéchot J. [Noninvasive assessment of liver fibrosis in patients with chronic hepatitis virus C]. Presse Med. 2006;35:1317-1326. [PMID: 16969327 DOI: 10.1016/s0755-4982(06)74811-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
181 Kim KM, Choi WB, Park SH, Yu E, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382-388. [PMID: 17530363 DOI: 10.1007/s00535-007-2016-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
182 Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, Patch D, Burroughs AK. Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. J Hepatol. 2007;47:284-294. [PMID: 17561303 DOI: 10.1016/j.jhep.2007.05.001] [Cited by in Crossref: 242] [Cited by in F6Publishing: 196] [Article Influence: 17.3] [Reference Citation Analysis]
183 Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006;130:1679-1687. [PMID: 16697732 DOI: 10.1053/j.gastro.2006.02.032] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 6.1] [Reference Citation Analysis]
184 Cross TJ, Calvaruso V, Maimone S, Carey I, Chang TP, Pleguezuelo M, Manousou P, Quaglia A, Grillo F, Dhillon AP. Prospective comparison of Fibroscan, King’s score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J Viral Hepat. 2010;17:546-554. [PMID: 19874477 DOI: 10.1111/j.1365-2893.2009.01210.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
185 Okumura A, Ishikawa T, Sato S, Yamauchi T, Oshima H, Ohashi T, Sato K, Ayada M, Hotta N, Kakumu S. Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4(+)CD25(+) T cells in patients with autoimmune hepatitis. Hepatol Res 2008;38:896-903. [PMID: 18624718 DOI: 10.1111/j.1872-034X.2008.00349.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
186 Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease. Korean J Hepatol. 2009;15:454-463. [PMID: 20037264 DOI: 10.3350/kjhep.2009.15.4.454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
187 Fujita K, Kuroda N, Morishita A, Oura K, Tadokoro T, Nomura T, Yoneyama H, Arai T, Himoto T, Watanabe S, Masaki T. Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection. J Clin Med. 2018;7. [PMID: 30208564 DOI: 10.3390/jcm7090267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
188 Gu Y, Chen L, Lian Y, Gu L, Chen Y, Bi Y, Huang Z, Huang Y, Hu B, Huang Y. Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment-naïve chronic hepatitis B patients. J Med Virol 2020;92:317-28. [PMID: 31642539 DOI: 10.1002/jmv.25612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
189 Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, Nobuoka T, Kimura Y, Hirata K. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 2006; 12(27): 4325-4330 [PMID: 16865773 DOI: 10.3748/wjg.v12.i27.4325] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
190 Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009;50:1-3. [PMID: 19017551 DOI: 10.1016/j.jhep.2008.10.014] [Cited by in Crossref: 193] [Cited by in F6Publishing: 173] [Article Influence: 14.8] [Reference Citation Analysis]
191 Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. King's Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009;21:730-738. [PMID: 19430302 DOI: 10.1097/meg.0b013e32830dfcb3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
192 Woo H, Lee JY, Yoon JH, Kim W, Cho B, Choi BI. Comparison of the Reliability of Acoustic Radiation Force Impulse Imaging and Supersonic Shear Imaging in Measurement of Liver Stiffness. Radiology. 2015;277:881-886. [PMID: 26147680 DOI: 10.1148/radiol.2015141975] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 8.8] [Reference Citation Analysis]
193 Papageorgiou MV, Papatheodoridis GV, Manolakopoulos S, Tsochatzis E, Kranidioti H, Kafiri G, Archimandritis AI. Elastography for hepatic fibrosis severity in chronic hepatitis B or C. Case Rep Gastroenterol 2011;5:63-72. [PMID: 21526140 DOI: 10.1159/000316635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
194 Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, Norha P, Munteanu M, Drane F, Messous D. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol. 2010;10:40. [PMID: 20412588 DOI: 10.1186/1471-230x-10-40] [Cited by in Crossref: 123] [Cited by in F6Publishing: 38] [Article Influence: 11.2] [Reference Citation Analysis]
195 Branchi F, Conti CB, Baccarin A, Lampertico P, Conte D, Fraquelli M. Non-invasive assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2014; 20(40): 14568-14580 [PMID: 25356021 DOI: 10.3748/wjg.v20.i40.14568] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
196 Martinez SM, Foucher J, Combis JM, Métivier S, Brunetto M, Capron D, Bourlière M, Bronowicki JP, Dao T, Maynard-Muet M, Lucidarme D, Merrouche W, Forns X, de Lédinghen V. Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy. PLoS One 2012;7:e47715. [PMID: 23082200 DOI: 10.1371/journal.pone.0047715] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
197 Leroy V, Halfon P, Bacq Y, Boursier J, Rousselet MC, Bourlière M, de Muret A, Sturm N, Hunault G, Penaranda G. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem. 2008;41:1368-1376. [PMID: 18655779 DOI: 10.1016/j.clinbiochem.2008.06.020] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
198 Moodie EE, Pant Pai N, Klein MB. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. PLoS One. 2009;4:e4517. [PMID: 19223976 DOI: 10.1371/journal.pone.0004517] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
199 Gabr SA, Alghadir AH, Sherif YE, Ghfar AA. Hydroxyproline as a Biomarker in Liver Disease. In: Patel VB, Preedy VR, editors. Biomarkers in Liver Disease. Dordrecht: Springer Netherlands; 2017. pp. 471-91. [DOI: 10.1007/978-94-007-7675-3_26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
200 Zeng J, Zhang X, Sun C, Pan Q, Lu WY, Chen Q, Huang LS, Fan JG. Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years. BMC Pediatr 2019;19:129. [PMID: 31018838 DOI: 10.1186/s12887-019-1487-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
201 Lewin M, Poujol-Robert A, Boëlle PY, Wendum D, Lasnier E, Viallon M, Guéchot J, Hoeffel C, Arrivé L, Tubiana JM. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007;46:658-665. [PMID: 17663420 DOI: 10.1002/hep.21747] [Cited by in Crossref: 199] [Cited by in F6Publishing: 181] [Article Influence: 14.2] [Reference Citation Analysis]
202 Lim JK, Tate JP, Fultz SL, Goulet JL, Conigliaro J, Bryant KJ, Gordon AJ, Gibert C, Rimland D, Goetz MB, Klein MB, Fiellin DA, Justice AC, Lo Re V 3rd. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis 2014;58:1449-58. [PMID: 24569533 DOI: 10.1093/cid/ciu097] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
203 Yoon JH, Lee JM, Kim E, Okuaki T, Han JK. Quantitative Liver Function Analysis: Volumetric T1 Mapping with Fast Multisection B1 Inhomogeneity Correction in Hepatocyte-specific Contrast-enhanced Liver MR Imaging. Radiology 2017;282:408-17. [PMID: 27697007 DOI: 10.1148/radiol.2016152800] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
204 Bedossa P. Histological Assessment of NAFLD. Dig Dis Sci. 2016;61:1348-1355. [PMID: 26874689 DOI: 10.1007/S10620-016-4052-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
205 Resino S, Asensio C, Bellón JM, Carmona R, Miralles P, López JC, Cosín J, Álvarez E, Berenguer J. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study. J Infect. 2011;63:402-405. [PMID: 21839774 DOI: 10.1016/j.jinf.2011.07.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
206 Chen YP, Dai L, Wang JL, Zhu YF, Feng XR, Hou JL. Model consisting of ultrasonographic and simple blood indexes accurately identify compensated hepatitis B cirrhosis. J Gastroenterol Hepatol. 2008;23:1228-1234. [PMID: 18637057 DOI: 10.1111/j.1440-1746.2008.05421.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
207 Shan QY, Liu BX, Tian WS, Wang W, Zhou LY, Wang Y, Xie XY. Elastography of shear wave speed imaging for the evaluation of liver fibrosis: A meta-analysis. Hepatol Res 2016;46:1203-13. [PMID: 26857658 DOI: 10.1111/hepr.12669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
208 Chon YE, Choi EH, Song KJ, Park JY, Kim DY, Han KH, Chon CY, Ahn SH, Kim SU. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One. 2012;7:e44930. [PMID: 23049764 DOI: 10.1371/journal.pone.0044930] [Cited by in Crossref: 179] [Cited by in F6Publishing: 172] [Article Influence: 19.9] [Reference Citation Analysis]
209 Morikawa H, Kawada N. Non-invasive diagnosis of liver fibrosis. Clin J Gastroenterol 2011;4:283-91. [DOI: 10.1007/s12328-011-0248-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
210 Teran-Hinojosa E, Sobral H, Sánchez-Pérez C, Pérez-García A, Alemán-García N, Hernández-Ruiz J. Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy. Biomed Opt Express 2017;8:3816-27. [PMID: 28856052 DOI: 10.1364/BOE.8.003816] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
211 Artz NS, Haufe WM, Hooker CA, Hamilton G, Wolfson T, Campos GM, Gamst AC, Schwimmer JB, Sirlin CB, Reeder SB. Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects. J Magn Reson Imaging 2015;42:811-7. [PMID: 25620624 DOI: 10.1002/jmri.24842] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 8.8] [Reference Citation Analysis]
212 Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat. 2006;13:659-670. [PMID: 16970597 DOI: 10.1111/j.1365-2893.2006.00736.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 6.4] [Reference Citation Analysis]
213 Wells SA. Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging. Magnetic Resonance Imaging Clinics of North America 2014;22:397-416. [DOI: 10.1016/j.mric.2014.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
214 Germani G, Burroughs AK, Dhillon AP. The relationship between liver disease stage and liver fibrosis: a tangled web. Histopathology. 2010;57:773-784. [PMID: 20812954 DOI: 10.1111/j.1365-2559.2010.03609.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
215 Cano A, Mariño Z, Millet O, Martínez-Arranz I, Navasa M, Falcón-Pérez JM, Pérez-Cormenzana M, Caballería J, Embade N, Forns X, Bosch J, Castro A, Mato JM. A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. Sci Rep 2017;7:10497. [PMID: 28874799 DOI: 10.1038/s41598-017-10807-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
216 Bang CS, Kang HY, Choi GH, Kim SB, Lee W, Song IH. The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis. Korean J Gastroenterol 2017;69:298-307. [PMID: 28539035 DOI: 10.4166/kjg.2017.69.5.298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
217 Halfon P, Munteanu M, Poynard T. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol. 2008;32:22-39. [PMID: 18973844 DOI: 10.1016/s0399-8320(08)73991-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
218 Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P, Seitz HK. Increased liver stiffness in alcoholic liver disease: Differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010; 16(8): 966-972 [PMID: 20180235 DOI: 10.3748/wjg.v16.i8.966] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 116] [Article Influence: 12.8] [Reference Citation Analysis]
219 Hoefs JC, Shiffman ML, Goodman ZD, Kleiner DE, Dienstag JL, Stoddard AM; HALT-C Trial Group. Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology 2011;141:900-908.e1-2. [PMID: 21699796 DOI: 10.1053/j.gastro.2011.06.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
220 Shi Y, Xia F, Li Q, Li J, Yu B, Li Y, An H, Glaser KJ, Tao S, Ehman RL, Guo Q. Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study. American Journal of Gastroenterology 2016;111:823-33. [DOI: 10.1038/ajg.2016.56] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
221 Porra L, Swan H, Ho C. The effect of applied transducer force on acoustic radiation force impulse quantification within the left lobe of the liver. Australas J Ultrasound Med 2015;18:100-6. [PMID: 28191250 DOI: 10.1002/j.2205-0140.2015.tb00208.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
222 Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Iwai T, Moriwaki EI, Shimomura S, Iijima H, Nakamura H, Nishiguchi S. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis. World J Hepatol 2012; 4(1): 11-17 [PMID: 22312451 DOI: 10.4254/wjh.v4.i1.11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
223 Verlinden W, Bourgeois S, Gigase P, Thienpont C, Vonghia L, Vanwolleghem T, Michielsen P, Francque S. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients. J Ultrasound Med 2016;35:1299-308. [PMID: 27151906 DOI: 10.7863/ultra.15.08066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
224 Soon G, Wee A. Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective. Clin Mol Hepatol 2021;27:44-57. [PMID: 33207115 DOI: 10.3350/cmh.2020.0181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
225 Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol. 2009;50:36-41. [PMID: 19012989 DOI: 10.1016/j.jhep.2008.07.039] [Cited by in Crossref: 180] [Cited by in F6Publishing: 174] [Article Influence: 13.8] [Reference Citation Analysis]
226 Nakao H, Yoneda M. Liver stiffness measurement using transient elastography and hepatocellular carcinoma. Hepatol Res 2011;41:921-4. [PMID: 21951870 DOI: 10.1111/j.1872-034X.2011.00895.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
227 Cadranel J, Castera L, Cales P. La ponction biopsie du foie dans le diagnostic et la prise en charge des maladies chroniques du foie. Gastroentérologie Clinique et Biologique 2006;30:121-3. [DOI: 10.1016/s0399-8320(06)73126-8] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
228 Ozturker C, Karagoz E, Incedayi M. Non-Invasive Evaluation of Liver Fibrosis: 2-D Shear Wave Elastography, Transient Elastography or Acoustic Radiation Force Impulse Imaging? Ultrasound in Medicine & Biology 2016;42:3052. [DOI: 10.1016/j.ultrasmedbio.2016.03.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
229 Kuo YH, Lu SN, Hung CH, Kee KM, Chen CH, Hu TH, Lee CM, Changchien CS, Wang JH. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int 2010;4:700-6. [PMID: 21286340 DOI: 10.1007/s12072-010-9223-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
230 Mohan P, Barton BA, Narkewicz MR, Molleston JP, Gonzalez-Peralta RP, Rosenthal P, Murray KF, Haber B, Schwarz KB, Goodman ZD. Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study. Hepatology. 2013;58:1580-1586. [PMID: 23703847 DOI: 10.1002/hep.26519] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
231 Attallah AM, El-Far M, Omran MM, Farid K, Albannan MS, El-Dosoky I. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J Clin Lab Anal 2013;27:121-9. [PMID: 23460258 DOI: 10.1002/jcla.21572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
232 Pockros PJ, Jeffers L, Afdhal N, Goodman ZD, Nelson D, Gish RG, Reddy KR, Reindollar R, Rodriguez-Torres M, Sullivan S. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology. 2007;45:569-578. [PMID: 17326152 DOI: 10.1002/hep.21561] [Cited by in Crossref: 90] [Cited by in F6Publishing: 74] [Article Influence: 6.4] [Reference Citation Analysis]
233 Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol. 2005;16:779-790. [PMID: 15947041 DOI: 10.1097/01.rvi.0000159543.28222.73] [Cited by in Crossref: 150] [Cited by in F6Publishing: 39] [Article Influence: 9.4] [Reference Citation Analysis]
234 Calvaruso V, Dhillon AP, Tsochatzis E, Manousou P, Grillo F, Germani G, Patch D, O'beirne J, Burroughs AK. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation: Collagen proportionate area and liver decompensation. Journal of Gastroenterology and Hepatology 2012;27:1227-32. [DOI: 10.1111/j.1440-1746.2012.07136.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
235 Zhou K, Hu F, Wang C, Xu M, Lan Y, Morano JP, Lemon SM, Tucker JD, Cai W. Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study. BMC Infect Dis 2015;15:401. [PMID: 26424404 DOI: 10.1186/s12879-015-1135-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
236 Hsieh YY, Tung SY, Lee K, Wu CS, Wei KL, Shen CH, Chang TS, Lin YH. Routine blood tests to predict liver fibrosis in chronic hepatitis C. World J Gastroenterol 2012; 18(8): 746-753 [PMID: 22371634 DOI: 10.3748/wjg.v18.i8.746] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
237 Naveau S, Gaudé G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prévot S, Ngo Y, Munteanu M. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009;49:97-105. [PMID: 19053048 DOI: 10.1002/hep.22576] [Cited by in Crossref: 183] [Cited by in F6Publishing: 159] [Article Influence: 15.3] [Reference Citation Analysis]
238 Park DW, Lee YJ, Chang W, Park JH, Lee KH, Kim YH, Kang NK, Chung JW, Jang HY, Ahn S, Kim H, Jeong SH, Kim JW, Jang ES. Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease. PLoS One 2019;14:e0212771. [PMID: 30856201 DOI: 10.1371/journal.pone.0212771] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
239 Omran D, Zayed RA, Nabeel MM, Mobarak L, Zakaria Z, Farid A, Hassany M, Saif S, Mostafa M, Saad OK, Yosry A. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients. Viral Immunol 2018;31:315-20. [PMID: 29630460 DOI: 10.1089/vim.2017.0134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
240 Ferenci P, Aires R, Beavers KL, Curescu M, Abrão Ferreira PR, Gschwantler M, Ion S, Larrey D, Maticic M, Puoti M, Schuller J, Tornai I, Tusnádi A, Messinger D, Tatsch F, Horban A. Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients. Hepatol Int 2014;8:83-93. [DOI: 10.1007/s12072-013-9484-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
241 Ydreborg M, Lisovskaja V, Lagging M, Brehm Christensen P, Langeland N, Buhl MR, Pedersen C, Mørch K, Wejstål R, Norkrans G, Lindh M, Färkkilä M, Westin J. A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. PLoS One 2014;9:e93601. [PMID: 24699777 DOI: 10.1371/journal.pone.0093601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
242 Halász T, Horváth G, Kiss A, Pár G, Szombati A, Gelley F, Nemes B, Kenessey I, Piurkó V, Schaff Z. Evaluation of Histological and non-Invasive Methods for the Detection of Liver Fibrosis: The Values of Histological and Digital Morphometric Analysis, Liver Stiffness Measurement and APRI Score. Pathol Oncol Res 2016;22:1-6. [PMID: 26189126 DOI: 10.1007/s12253-015-9964-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
243 Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, Mchutchison JG. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBRO Spect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. Journal of Viral Hepatitis 2009;16:178-86. [DOI: 10.1111/j.1365-2893.2008.01062.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
244 Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM, Ehman RL, Venkatesh SK. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics. 2016;36:1987-2006. [PMID: 27689833 DOI: 10.1148/rg.2016160042] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 18.4] [Reference Citation Analysis]
245 Castera L, Bedossa P. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy? Liver Int. 2011;31 Suppl 1:13-17. [PMID: 21205132 DOI: 10.1111/j.1478-3231.2010.02380.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
246 de Lédinghen V, Barreiro P, Foucher J, Labarga P, Castéra L, Vispo ME, Bernard PH, Martin-Carbonero L, Neau D, García-Gascó P. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat. 2008;15:427-433. [PMID: 18221303 DOI: 10.1111/j.1365-2893.2007.00962.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
247 Jamialahmadi T, Nematy M, Jangjoo A, Goshayeshi L, Rezvani R, Ghaffarzadegan K, Nooghabi MJ, Shalchian P, Zangui M, Javid Z, Doaei S, Rajabzadeh F. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.Obes Surg. 2019;29:2585-2592. [PMID: 31077025 DOI: 10.1007/s11695-019-03889-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
248 Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB; Canadian Co-infection Cohort Investigators. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis. Clin Infect Dis 2013;57:663-70. [PMID: 23811492 DOI: 10.1093/cid/cit378] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
249 Brunt EM. Histopathology of Non-Alcoholic Fatty Liver Disease. Clinics in Liver Disease 2009;13:533-44. [DOI: 10.1016/j.cld.2009.07.008] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 7.6] [Reference Citation Analysis]
250 Cepeda JA, Solomon SS, Srikrishnan AK, Nandagopal P, Balakrishnan P, Kumar MS, Thomas DL, Sulkowski MS, Mehta SH. Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India. Open Forum Infect Dis 2016;3:ofw156. [PMID: 27704012 DOI: 10.1093/ofid/ofw156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
251 Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54:64-71. [PMID: 20932598 DOI: 10.1016/j.jhep.2010.06.022] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 14.4] [Reference Citation Analysis]
252 Fang C, Sidhu PS. Ultrasound-based liver elastography: current results and future perspectives. Abdom Radiol (NY). 2020;45:3463-3472. [PMID: 32918106 DOI: 10.1007/s00261-020-02717-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
253 Ueda N, Kawaoka T, Imamura M, Aikata H, Nakahara T, Murakami E, Tsuge M, Hiramatsu A, Hayes CN, Yokozaki M, Chayama K. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection. BMC Gastroenterol 2020;20:314. [PMID: 32977741 DOI: 10.1186/s12876-020-01459-w] [Reference Citation Analysis]
254 Jang HW, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Park YN, Choi EH, Kim do Y. How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements. Yonsei Med J. 2012;53:337-345. [PMID: 22318821 DOI: 10.3349/ymj.2012.53.2.337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
255 Halfon P. Les limites du fibrotest dans la prise en charge de l’hépatite C. Gastroentérologie Clinique et Biologique 2006;30:117-20. [DOI: 10.1016/s0399-8320(06)73125-6] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
256 Jiang H, Zheng T, Duan T, Chen J, Song B. Non-invasive in vivo Imaging Grading of Liver Fibrosis. J Clin Transl Hepatol. 2018;6:198-207. [PMID: 29951365 DOI: 10.14218/jcth.2017.00038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
257 Sang Y, Wang X, Yu P, Zhang L, Dai Y, Zhang L, Wang D, Liu Z, Wang Y, Tao Z. Prostatic aspirated cellular RNA analysis enables fast diagnosis and staging of prostate cancer. Transl Oncol 2021;14:100963. [PMID: 33248415 DOI: 10.1016/j.tranon.2020.100963] [Reference Citation Analysis]
258 Fernandes SA, Cooper GE, Gibson RA, Kishnani PS. Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX. Mol Genet Metab 2020;131:299-305. [PMID: 33317799 DOI: 10.1016/j.ymgme.2020.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
259 Gabr SA, Alghadir AH. Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers. Virusdisease 2014;25:91-100. [PMID: 24426315 DOI: 10.1007/s13337-013-0182-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
260 Pokorska-Śpiewak M, Kowalik-Mikołajewska B, Aniszewska M, Pluta M, Marczyńska M. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol 2015; 21(42): 12141-12149 [PMID: 26576098 DOI: 10.3748/wjg.v21.i42.12141] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
261 Baudi I, Inoue T, Tanaka Y. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi. Int J Mol Sci. 2020;21. [PMID: 32023902 DOI: 10.3390/ijms21030949] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
262 Campa A, Martinez SS, Sherman KE, Greer JP, Li Y, Garcia S, Stewart T, Ibrahimou B, Williams OD, Baum MK. Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort. J Drug Abuse 2016;2:27. [PMID: 28540368 DOI: 10.21767/2471-853X.100036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
263 Zhang C, Liu H, Cui Y, Li X, Zhang Z, Zhang Y, Wang D. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model. Int J Nanomedicine 2016;11:1097-108. [PMID: 27051285 DOI: 10.2147/IJN.S101366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
264 Sporea I, Şirli R, Bota S, Fierbinţeanu-Braticevici C, Petrişor A, Badea R, Lupşor M, Popescu A, Dănilă M. Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis? World J Radiol 2011; 3(7): 188-193 [PMID: 21860715 DOI: 10.4329/wjr.v3.i7.188] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
265 Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, Lok AS, Wright EC, Su GL; HALT-C Trial Group. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut 2010;59:1401-9. [PMID: 20675691 DOI: 10.1136/gut.2010.207423] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
266 Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ;  Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104-1112. [PMID: 19523535 DOI: 10.1016/j.cgh.2009.05.033] [Cited by in Crossref: 620] [Cited by in F6Publishing: 561] [Article Influence: 51.7] [Reference Citation Analysis]
267 Villani R, Cavallone F, Romano AD, Bellanti F, Serviddio G. Two-Dimensional Shear Wave Elastography versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C. Diagnostics (Basel) 2020;10:E313. [PMID: 32429410 DOI: 10.3390/diagnostics10050313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
268 Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS 2012;26:599-607. [PMID: 22156972 DOI: 10.1097/QAD.0b013e32834fa121] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
269 Resino S, Micheloud D, Miralles P, Bellã³n J, Vargas A, Catalã¡n P, Álvarez E, Cosã­n J, Lorente R, Lã³pez J, Muã±oz-fernã¡ndez M, Berenguer J. Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index: Diagnosis of advanced fibrosis. HIV Medicine 2010;11:64-73. [DOI: 10.1111/j.1468-1293.2009.00745.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
270 Marcellin P, Wong DK, Sievert W, Buggisch P, Petersen J, Flisiak R, Manns M, Kaita K, Krastev Z, Lee SS, Cathcart AL, Crans G, Op den Brouw M, Jump B, Gaggar A, Flaherty J, Buti M. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. Liver Int. 2019;39:1868-1875. [PMID: 31136052 DOI: 10.1111/liv.14155] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 19.5] [Reference Citation Analysis]
271 Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J MagnReson Imaging. 2010;31:589-600. [PMID: 20187201 DOI: 10.1002/jmri.22081] [Cited by in Crossref: 286] [Cited by in F6Publishing: 270] [Article Influence: 26.0] [Reference Citation Analysis]
272 Sharma P, Dhawan S, Bansal R, Tyagi P, Bansal N, Singla V, Kumar A, Matin A, Arora A. Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis. Indian J Gastroenterol. 2014;33:445-451. [PMID: 25138787 DOI: 10.1007/s12664-014-0491-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
273 Matas M, Picornell A, Cifuentes C, Payeras A, Bassa A, Homar F, González-Candelas F, López-Labrador FX, Moya A, Ramon MM, Castro JA. Generalized Linear Model (GLM) framework for the association of host variables and viral strains with liver fibrosis in HCV/HIV coinfected patients. Infect Genet Evol 2013;13:284-91. [PMID: 23174528 DOI: 10.1016/j.meegid.2012.10.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
274 Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol. 2012;18:109-162. [PMID: 22893865 DOI: 10.3350/cmh.2012.18.2.109] [Cited by in Crossref: 109] [Cited by in F6Publishing: 121] [Article Influence: 12.1] [Reference Citation Analysis]
275 Vergniol J, de Lédinghen V. [Transient elastography (FibroScan): a new tool in hepatology]. Presse Med. 2009;38:1516-1525. [PMID: 19195821 DOI: 10.1016/j.lpm.2008.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
276 Riley TR 3rd, Ruggiero FM. The effect of processing on liver biopsy core size. Dig Dis Sci 2008;53:2775-7. [PMID: 18270834 DOI: 10.1007/s10620-007-0181-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
277 Poynard T, Munteanu M, Ngo Y, Moussalli J, Lebray P, Thabut D, Benhamou Y, Ratziu V. FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence. J Viral Hepat 2008;15:472-3. [DOI: 10.1111/j.1365-2893.2008.00986.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
278 Lo Re V 3rd, Kostman JR, Amorosa VK. Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis 2008;12:587-609, ix. [PMID: 18625430 DOI: 10.1016/j.cld.2008.03.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
279 Zhang X, Xu R, Hu X, Luo G, Wu J, He W. A systematic and quantitative method for wound-dressing evaluation. Burns Trauma 2015;3:15. [PMID: 27574661 DOI: 10.1186/s41038-015-0013-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
280 Kim BH, Lee JM, Lee YJ, Lee KB, Suh KS, Han JK, Choi BI. MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging. 2011;34:1110-1116. [PMID: 21932355 DOI: 10.1002/jmri.22723] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
281 Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo Y, Goldin RD, Taylor-robinson SD. 31P MR Spectroscopy in Assessment of Response to Antiviral Therapy for Hepatitis C Virus–Related Liver Disease. American Journal of Roentgenology 2007;189:819-23. [DOI: 10.2214/ajr.07.2418] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
282 Touré PS, Léye A, Diop MM, Gueye MD, Léye YM, Berthé A, Ka MM. [Liver biopsy in Dakar: indications, complications and diagnostic contribution--about 70 cases]. Pan Afr Med J 2014;17:85. [PMID: 25452831 DOI: 10.11604/pamj.2014.17.85.2703] [Reference Citation Analysis]
283 Unal E, Idilman IS, Karçaaltıncaba M. Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era. Expert Rev Gastroenterol Hepatol 2017;11:167-82. [PMID: 27937040 DOI: 10.1080/17474124.2017.1271710] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
284 Cheung KJ, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Proteomics in liver fibrosis is more than meets the eye: . European Journal of Gastroenterology & Hepatology 2008;20:450-64. [DOI: 10.1097/meg.0b013e3282f4de92] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
285 Lesmana CR, Salim S, Hasan I, Sulaiman AS, Gani RA, Pakasi LS, Lesmana LA, Krisnuhoni E, Budihusodo U. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting. J Clin Pathol. 2011;64:916-920. [PMID: 21670074 DOI: 10.1136/jclinpath-2011-200044] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
286 Yang X, Chang X, Wu S, Sun X, Zhu X, Wang L, Xu Y, Yao X, Rao S, Hu X, Xia M, Bian H, Yan H, Gao X. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease. Lipids Health Dis 2021;20:27. [PMID: 33757528 DOI: 10.1186/s12944-021-01453-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 Gori M, Arciello M, Balsano C. MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int. 2014;2014:741465. [PMID: 24745023 DOI: 10.1155/2014/741465] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
288 Phelps A, Ramachandran R, Courtier J, Perito E, Rosenthal P, Mackenzie JD. Ultrasound elastography: is there a shear wave speed cutoff for pediatric liver fibrosis and inflammation? Clinical Imaging 2017;41:95-100. [DOI: 10.1016/j.clinimag.2016.10.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
289 Trang T, Petersen JR, Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta. 2008;397:51-54. [PMID: 18692034 DOI: 10.1016/j.cca.2008.07.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
290 Aragonès G, Auguet T, Berlanga A, Guiu-Jurado E, Martinez S, Armengol S, Sabench F, Ras R, Hernandez M, Aguilar C, Colom J, Sirvent JJ, Del Castillo D, Richart C. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. PLoS One 2016;11:e0154601. [PMID: 27123846 DOI: 10.1371/journal.pone.0154601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
291 Murata A, Amano N, Sato S, Tsuzura H, Tomishima K, Sato S, Matsumoto K, Shimada Y, Iijima K, Genda T. On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy. Int J Mol Sci 2020;21:E2051. [PMID: 32192084 DOI: 10.3390/ijms21062051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
292 Ibáñez JG, Pérez M, Lamas JL, Ocampo A, Vázquez CM, Ribera A. [Grade of consistency existing in the grade of hepatic fibrosis calculated with the APRI and FORNS biochemistry indexes and transient elastography (Fibroscan in patients coinfected with HIV-HCV]. Rev Clin Esp 2010;210:317-22. [PMID: 20466359 DOI: 10.1016/j.rce.2010.02.006] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
293 Aita JS, Harrison SA. Liver biopsy versus noninvasive testing in chronic hepatitis C: Where do we stand in 2008? Curr hepatitis rep 2008;7:51-9. [DOI: 10.1007/s11901-008-0008-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
294 Boursier J, Dib N, Oberti F, Calès P. Caractéristiques et interprétation des tests sanguins de fibrose hépatique. Gastroentérologie Clinique et Biologique 2007;31:511-23. [DOI: 10.1016/s0399-8320(07)89421-8] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
295 Bedossa P. Current histological classification of NAFLD: Strength and limitations. Hepatol Int. 2013;7 Suppl 2:765-770. [PMID: 26202292 DOI: 10.1007/s12072-013-9446-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
296 Chi H, Hansen BE, Tang WY, Schouten JN, Sprengers D, Taimr P, Janssen HL, de Knegt RJ. Multiple biopsy passes and the risk of complications of percutaneous liver biopsy: . European Journal of Gastroenterology & Hepatology 2017;29:36-41. [DOI: 10.1097/meg.0000000000000731] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
297 Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: clinical applications. J Comput Assist Tomogr. 2013;37:887-896. [PMID: 24270110 DOI: 10.1097/rct.0000000000000032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 7.1] [Reference Citation Analysis]
298 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1016/s0140-6736(08)60383-9] [Cited by in Crossref: 1212] [Cited by in F6Publishing: 536] [Article Influence: 93.2] [Reference Citation Analysis]
299 Yu ML, Lin SM, Lee CM, Dai CY, Chang WY, Chen SC, Lee LP, Lin ZY, Hsieh MY, Wang LY, Chuang WL, Liaw YF. A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy. Hepatology. 2006;44:1086-1097. [PMID: 17058238 DOI: 10.1002/hep.21363] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
300 Brunt EM. Do you see what I see? The role of quality histopathology in scientific study. Hepatology 2008;47:771-4. [DOI: 10.1002/hep.22185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
301 Sagnelli C, Martini S, Pisaturo M, Pasquale G, Macera M, Zampino R, Coppola N, Sagnelli E. Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact. World J Hepatol 2015; 7(24): 2510-2521 [PMID: 26523204 DOI: 10.4254/wjh.v7.i24.2510] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
302 Kennedy P, Wagner M, Castéra L, Hong CW, Johnson CL, Sirlin CB, Taouli B. Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. Radiology 2018;286:738-63. [PMID: 29461949 DOI: 10.1148/radiol.2018170601] [Cited by in Crossref: 119] [Cited by in F6Publishing: 106] [Article Influence: 39.7] [Reference Citation Analysis]
303 Stefanescu AC, Pop TL, Stefanescu H, Miu N. Transient elastography of the liver in children with Wilson's disease: Preliminary results. J Clin Ultrasound 2016;44:65-71. [PMID: 26177868 DOI: 10.1002/jcu.22281] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
304 Lidbury JA. Getting the Most Out of Liver Biopsy. Vet Clin North Am Small Anim Pract. 2017;47:569-583. [PMID: 28081862 DOI: 10.1016/j.cvsm.2016.11.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
305 Mendoza J, Gómez-Domínguez E, Moreno-Otero R. [Transient elastography (Fibroscan), a new non-invasive method to evaluate hepatic fibrosis]. Med Clin (Barc) 2006;126:220-2. [PMID: 16510096 DOI: 10.1157/13084871] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
306 Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, Chen ZE, Bolster BD, Shah S, Miller FH. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging. 2012;35:1356-1364. [PMID: 22246952 DOI: 10.1002/jmri.23585] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 10.1] [Reference Citation Analysis]
307 Krawitt EL. Sampling variability in liver biopsies. J Hepatol 2004;41:886-7. [PMID: 15519668 DOI: 10.1016/j.jhep.2004.05.023] [Reference Citation Analysis]
308 Yu SJ, Lee JH, Chung GE, Lee CH, Cho EJ, Jang ES, Kwak MS, Kim YJ, Yoon JH, Jang JJ, Lee HS. Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma. Korean J Hepatol 2010;16:389-96. [PMID: 21415583 DOI: 10.3350/kjhep.2010.16.4.389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
309 Tag-Adeen M, Omar MZ, Abd-Elsalam FM, Hasaneen A, Mohamed MA, Elfeky HM, Said EM, Abdul-Aziz B, Osman AH, Ahmed ES, Osman GS, Abdul-Samie T. Assessment of liver fibrosis in Egyptian chronic hepatitis B patients: A comparative study including 5 noninvasive indexes. Medicine (Baltimore) 2018;97:e9781. [PMID: 29419671 DOI: 10.1097/MD.0000000000009781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
310 Carrión JA, Fernández-Varo G, Bruguera M, García-Pagán JC, García-Valdecasas JC, Pérez-Del-Pulgar S, Forns X, Jiménez W, Navasa M. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation. Gastroenterology. 2010;138:147-158.e1. [PMID: 19786026 DOI: 10.1053/j.gastro.2009.09.047] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
311 Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, de Knegt RJ, van Vuuren AJ. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol. 2011;46:962-972. [PMID: 21623677 DOI: 10.3109/00365521.2011.574725] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
312 Miailhes P, Pradat P, Chevallier M, Lacombe K, Bailly F, Cotte L, Trabaud MA, Boibieux A, Bottero J, Trepo C. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients. J Viral Hepat. 2011;18:61-69. [PMID: 20196798 DOI: 10.1111/j.1365-2893.2010.01275.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
313 Kühn JP, Meffert P, Heske C, Kromrey ML, Schmidt CO, Mensel B, Völzke H, Lerch MM, Hernando D, Mayerle J, Reeder SB. Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging. Radiology 2017;284:706-16. [PMID: 28481195 DOI: 10.1148/radiol.2017161228] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 12.0] [Reference Citation Analysis]
314 Boursier J, Isselin G, Fouchard-Hubert I, Oberti F, Dib N, Lebigot J, Bertrais S, Gallois Y, Calès P, Aubé C. Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol. 2010;22:1074-1084. [PMID: 20440210 DOI: 10.1097/meg.0b013e328339e0a1] [Cited by in Crossref: 97] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
315 Schuppan D, Popov Y. Rationale and targets for antifibrotic therapies. Gastroenterol Clin Biol 2009;33:949-57. [PMID: 19726145 DOI: 10.1016/j.gcb.2009.07.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
316 Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB; American Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12:289-299. [PMID: 20590901 DOI: 10.1111/j.1477-2574.2010.00181.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 99] [Article Influence: 11.1] [Reference Citation Analysis]
317 Breton E, Bridoux-Henno L, Guyader D, Daniélou H, Jouan H, Beuchée A, Nousbaum JB, Dabadie A. [Value of transient elastography in noninvasive assessment in children’s hepatic fibrosis]. Arch Pediatr. 2009;16:1005-1010. [PMID: 19446446 DOI: 10.1016/j.arcped.2009.03.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
318 Nakamura Y, Aikata H, Fukuhara T, Honda F, Morio K, Morio R, Hatooka M, Kobayashi T, Nagaoki Y, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Kobayashi T, Ohdan H, Shiroma N, Arihiro K, Chayama K. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection: Assessing liver fibrosis by FibroScan. Hepatol Res 2017;47:767-72. [DOI: 10.1111/hepr.12815] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
319 Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, Messous D, Bismut FI, Roulot D, Benhamou Y. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One. 2008;3:e3857. [PMID: 19052646 DOI: 10.1371/journal.pone.0003857] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
320 Poynard T, Munteanu M, Ngo Y, Castera L, Halfon P, Ratziu V, Imbert-Bismut F, Thabut D, Bourliere M, Cacoub P. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol. 2010;34:388-396. [PMID: 20580175 DOI: 10.1016/j.gcb.2010.05.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
321 Pijls KE, Smolinska A, Jonkers DM, Dallinga JW, Masclee AA, Koek GH, van Schooten FJ. A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis. Sci Rep. 2016;6:19903. [PMID: 26822454 DOI: 10.1038/srep19903] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
322 Petersen JR, Stevenson HL, Kasturi KS, Naniwadekar A, Parkes J, Cross R, Rosenberg WM, Xiao SY, Snyder N. Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C. J Clin Gastroenterol. 2014;48:370-376. [PMID: 24045284 DOI: 10.1097/mcg.0b013e3182a87e78] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
323 Xie S, Li Q, Cheng Y, Zhang Y, Zhuo Z, Zhao G, Shen W. Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study. Korean J Radiol 2017;18:898-905. [PMID: 29089822 DOI: 10.3348/kjr.2017.18.6.898] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
324 J.s. Cross T, Jothimani D, Heneghan MA, Harrison PM. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence: Non-invasive assessment of HCV post OLT. Clinical Transplantation 2011;25:345-51. [DOI: 10.1111/j.1399-0012.2011.01396.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
325 European Association For The Study Of The Liver. [EASL clinical practice guidelines. Management of chronic hepatitis B]. Gastroenterol Clin Biol. 2009;33:539-554. [PMID: 19481389 DOI: 10.1016/j.gcb.2009.03.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
326 Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis. 2013;57:240-246. [PMID: 23592832 DOI: 10.1093/cid/cit245] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 11.1] [Reference Citation Analysis]
327 Chang PE, Lui HF, Chau YP, Lim KH, Yap WM, Tan CK, Chow WC. Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. Aliment Pharmacol Ther. 2008;28:51-61. [PMID: 18410556 DOI: 10.1111/j.1365-2036.2008.03711.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
328 Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006;55:569-78. [PMID: 16531536 DOI: 10.1136/gut.2005.084475] [Cited by in Crossref: 275] [Cited by in F6Publishing: 246] [Article Influence: 18.3] [Reference Citation Analysis]
329 Giannini EG, Zaman A, Ceppa P, Mastracci L, Risso D, Testa R. A Simple Approach to Noninvasively Identifying Significant Fibrosis in Chronic Hepatitis C Patients in Clinical Practice: . Journal of Clinical Gastroenterology 2006;40:521-7. [DOI: 10.1097/00004836-200607000-00011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
330 Poynard T, Munteanu M, Luckina E, Perazzo H, Ngo Y, Royer L, Fedchuk L, Sattonnet F, Pais R, Lebray P. Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. J Hepatol. 2013;58:928-935. [PMID: 23321316 DOI: 10.1016/j.jhep.2012.12.021] [Cited by in Crossref: 122] [Cited by in F6Publishing: 107] [Article Influence: 15.3] [Reference Citation Analysis]
331 Tibuakuu M, Jjingo C, Kirk GD, Thomas DL, Gray R, Ssempijja V, Nalugoda F, Serwadda D, Ocama P, Opio CK, Kleiner DE, Quinn TC, Reynolds SJ. Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans. J Viral Hepat 2020;27:1022-31. [PMID: 32388879 DOI: 10.1111/jvh.13320] [Reference Citation Analysis]
332 Zhang D, Li P, Chen M, Liu L, Liu Y, Zhao Y, Wang R. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease using acoustic radiation force impulse elastography. Abdom Imaging. 2015;40:723-729. [PMID: 24811766 DOI: 10.1007/s00261-014-0154-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
333 Zhan YT, Li L, Weng J, Song X, Yang SQ, An W. Serum autofluorescence, a potential serum marker for the diagnosis of liver fibrosis in rats. Int J Mol Sci. 2012;13:12130-12139. [PMID: 23109905 DOI: 10.3390/ijms130912130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
334 Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, Lok AS, Wright EC, Su GL. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. 2010;59:1401-1409. [PMID: 20675691 DOI: 10.1136/gut.2010.207423.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
335 Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008;134:1670-1681. [PMID: 18471546 DOI: 10.1053/j.gastro.2008.03.001] [Cited by in Crossref: 289] [Cited by in F6Publishing: 271] [Article Influence: 22.2] [Reference Citation Analysis]
336 Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV. Systematic review: hepatic fibrosis - regression with therapy. Aliment Pharmacol Ther 2008;28:1175-87. [PMID: 18761707 DOI: 10.1111/j.1365-2036.2008.03840.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
337 Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2013;7:356-68. [PMID: 26201770 DOI: 10.1007/s12072-013-9439-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
338 Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Løberg EM, Haukeland JW. Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver. Scand J Gastroenterol. 2013;48:93-100. [PMID: 23205894 DOI: 10.3109/00365521.2012.746389] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
339 Du D, Zhu X, Kuno A, Matsuda A, Tsuruno C, Yu D, Zhang Y, Ikehara Y, Tanaka Y, Zhang X. Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels. Clin Chim Acta. 2012;413:1796-1799. [PMID: 22796373 DOI: 10.1016/j.cca.2012.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
340 Everson GT, Shiffman ML, Morgan TR, Hoefs JC, Sterling RK, Wagner DA, Kulig CC, Curto TM, Wright EC; Halt-C Trial Group. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial. Aliment Pharmacol Ther 2008;27:798-809. [PMID: 18266997 DOI: 10.1111/j.1365-2036.2008.03639.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
341 Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat. 2009;16:300-314. [PMID: 19254351 DOI: 10.1111/j.1365-2893.2009.01087.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 9.4] [Reference Citation Analysis]
342 Kim SU, Jang HW, Cheong JY, Kim JK, Lee MH, Kim DJ, Yang JM, Cho SW, Lee KS, Choi EH. The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study. J Gastroenterol Hepatol. 2011;26:171-178. [PMID: 21175811 DOI: 10.1111/j.1440-1746.2010.06385.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
343 Scott R, Guha IN. Non-invasive monitoring of liver fibrosis. British Medical Bulletin 2014;112:97-106. [DOI: 10.1093/bmb/ldu031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
344 Sebastiani G, Halfon P, Castera L, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C: Combination algorithms for liver fibrosis in HCV. Alimentary Pharmacology & Therapeutics 2012;35:92-104. [DOI: 10.1111/j.1365-2036.2011.04897.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
345 Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS. Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. J Korean Med Sci. 2010;25:67-74. [PMID: 20052350 DOI: 10.3346/jkms.2010.25.1.67] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
346 Vinciguerra T, Brunati A, David E, Longo F, Pinon M, Ricceri F, Castellino L, Piga A, Giraudo MT, Tandoi F. Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children. Pediatr Transplant. 2018;22. [PMID: 29369488 DOI: 10.1111/petr.13125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
347 Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C. Clin Chim Acta. 2007;381:119-123. [PMID: 17442291 DOI: 10.1016/j.cca.2007.02.046] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
348 Cho HJ, Kim SS, Ahn SJ, Bae CB, Kim HG, Kim YJ, Lee SK, Song GW, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW, Cheong JY. Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B. Clin Biochem 2012;45:1564-7. [PMID: 22885475 DOI: 10.1016/j.clinbiochem.2012.07.107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
349 Melero-ferrer JL, Osa-sáez A, Buendía-fuentes F, Ballesta-cuñat A, Flors L, Rodríguez-serrano M, Calvillo-batllés P, Arnau-vives M, Palencia-pérez MA, Rueda-soriano J. Fontan Circulation in Adult Patients: Acoustic Radiation Force Impulse Elastography as a Useful Tool for Liver Assessment. World J Pediatr Congenit Heart Surg 2014;5:365-71. [DOI: 10.1177/2150135114530172] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
350 Huang M, Lu X, Wang X, Shu J. Diffusion tensor imaging quantifying the severity of chronic hepatitis in rats. BMC Med Imaging 2020;20:74. [PMID: 32615932 DOI: 10.1186/s12880-020-00466-3] [Reference Citation Analysis]
351 Mumtaz S, Schomaker N, Von Roenn N. Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken) 2019;13:111-3. [PMID: 31061704 DOI: 10.1002/cld.750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
352 Ruhwald M, Andersen ES, Christensen PB, Moessner BK, Weis N. IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection. PLoS One 2012;7:e45181. [PMID: 23024806 DOI: 10.1371/journal.pone.0045181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
353 Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V; LIDO Study Group; CYTOL study group. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006;6:34. [PMID: 17096854 DOI: 10.1186/1471-230x-6-34] [Cited by in Crossref: 186] [Cited by in F6Publishing: 73] [Article Influence: 12.4] [Reference Citation Analysis]
354 Srinivasan I, Tang SJ, Vilmann AS, Menachery J, Vilmann P. Hepatic applications of endoscopic ultrasound: Current status and future directions. World J Gastroenterol 2015; 21(44): 12544-12557 [PMID: 26640331 DOI: 10.3748/wjg.v21.i44.12544] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
355 Embade N, Mariño Z, Diercks T, Cano A, Lens S, Cabrera D, Navasa M, Falcón-Pérez JM, Caballería J, Castro A, Bosch J, Mato JM, Millet O. Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy. PLoS One 2016;11:e0155094. [PMID: 27158896 DOI: 10.1371/journal.pone.0155094] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
356 Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C. PLoS One. 2013;8:e59088. [PMID: 23555619 DOI: 10.1371/journal.pone.0059088.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
357 Carpentier A, Conti F, Carrière M, Aoudjehane L, Miroux C, Moralès O, Calmus Y, Groux H, Auriault C, Pancré V, Delhem N, Podevin P. Analysis of gene transcription in sera during chronic hepatitis C infection. J Med Virol 2009;81:473-80. [PMID: 19152403 DOI: 10.1002/jmv.21398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
358 Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V. Biomarkers of liver fibrosis. Adv Clin Chem. 2008;46:131-160. [PMID: 19004189 DOI: 10.1016/s0065-2423(08)00404-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
359 Cassinotto C, Lapuyade B, Mouries A, Hiriart J, Vergniol J, Gaye D, Castain C, Le Bail B, Chermak F, Foucher J, Laurent F, Montaudon M, De Ledinghen V. Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan®. Journal of Hepatology 2014;61:550-7. [DOI: 10.1016/j.jhep.2014.04.044] [Cited by in Crossref: 214] [Cited by in F6Publishing: 179] [Article Influence: 30.6] [Reference Citation Analysis]
360 Nielsen MJ, Kazankov K, Leeming DJ, Karsdal MA, Krag A, Barrera F, McLeod D, George J, Grønbæk H. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients. PLoS One 2015;10:e0137302. [PMID: 26406331 DOI: 10.1371/journal.pone.0137302] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
361 Martinez SM, Fernández-Varo G, González P, Sampson E, Bruguera M, Navasa M, Jiménez W, Sánchez-Tapias JM, Forns X. Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2011;33:138-148. [PMID: 21083589 DOI: 10.1111/j.1365-2036.2010.04500.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
362 Hagan M, Asrani SK, Talwalkar J. Non-invasive assessment of liver fibrosis and prognosis. Expert Review of Gastroenterology & Hepatology 2015;9:1251-60. [DOI: 10.1586/17474124.2015.1075391] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
363 Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li MK, Chan HL. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 2011;26:300-5. [PMID: 21261720 DOI: 10.1111/j.1440-1746.2010.06510.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 9.8] [Reference Citation Analysis]
364 Theise ND, Bodenheimer HC, Ferrell LD. Acute and chronic viral hepatitis. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 361-401. [DOI: 10.1016/b978-0-7020-3398-8.00007-6] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
365 Schierwagen R, Leeming DJ, Klein S, Granzow M, Nielsen MJ, Sauerbruch T, Krag A, Karsdal MA, Trebicka J. Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats. Front Physiol 2013;4:195. [PMID: 23908632 DOI: 10.3389/fphys.2013.00195] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
366 Lee JM, Seo YS, Kim TH, Ahn JM, Yim SY, Kim SU, Jung YK, Kim JH, An H, Yim HJ, Yeon JE, Lee HS, Byun KS, Um SH, Kim CD, Ryu HS. The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B. J Gastroenterol Hepatol 2017;32:208-14. [PMID: 27194632 DOI: 10.1111/jgh.13447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
367 Pockros PJ. Noninvasive Markers of Fibrosis in Chronic Hepatitis Patients: . Journal of Clinical Gastroenterology 2006;40:461-3. [DOI: 10.1097/00004836-200607000-00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
368 Lee MH, Shin HJ, Yoon H, Han SJ, Koh H, Lee MJ. Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis. World J Gastroenterol 2020; 26(21): 2821-2830 [PMID: 32550757 DOI: 10.3748/wjg.v26.i21.2821] [Reference Citation Analysis]
369 Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-carrie N, Kazemi F, Grando-lemaire V, Trinchet J, Beaugrand M. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Alimentary Pharmacology & Therapeutics 2008;28:1102-10. [DOI: 10.1111/j.1365-2036.2008.03825.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 127] [Article Influence: 11.2] [Reference Citation Analysis]
370 Scoazec JY. [Liver biopsy: Which role in patient management?]. Ann Pathol 2010;30:464-9. [PMID: 21167433 DOI: 10.1016/j.annpat.2010.08.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
371 Kemp SD, Zimmerman KL, Panciera DL, Monroe WE, Leib MS, Lanz OI. A comparison of liver sampling techniques in dogs. J Vet Intern Med 2015;29:51-7. [PMID: 25417960 DOI: 10.1111/jvim.12508] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
372 Kumagai H, Yokoyama K, Katsuyama K, Hara S, Yamamoto H, Yamagata T, Taniguchi N, Hirota N, Itoh K. A New Method for Measuring the Speed of Sound in Rat Liver ex Vivo Using an Ultrasound System: Correlation of Sound Speed with Fat Deposition. Ultrasound in Medicine & Biology 2014;40:2499-507. [DOI: 10.1016/j.ultrasmedbio.2014.03.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
373 Crespo G, Fernández-varo G, Mariño Z, Casals G, Miquel R, Martínez SM, Gilabert R, Forns X, Jiménez W, Navasa M. ARFI, FibroScan®, ELF, and their combinations in the assessment of liver fibrosis: A prospective study. Journal of Hepatology 2012;57:281-7. [DOI: 10.1016/j.jhep.2012.03.016] [Cited by in Crossref: 109] [Cited by in F6Publishing: 100] [Article Influence: 12.1] [Reference Citation Analysis]
374 Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Penaranda G, Bar-meir S, Martinowitz U, Halfon P. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy? Haemophilia 2006;12:372-9. [DOI: 10.1111/j.1365-2516.2006.01290.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
375 Lebensztejn DM, Sobaniec-Łotowska ME, Bauer M, Kaczmarski M, Voelker M, Schuppan D. Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B. Eur J Gastroenterol Hepatol 2005;17:843-8. [PMID: 16003134 DOI: 10.1097/00042737-200508000-00011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
376 Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2007;5:1214-20. [DOI: 10.1016/j.cgh.2007.07.020] [Cited by in Crossref: 327] [Cited by in F6Publishing: 305] [Article Influence: 23.4] [Reference Citation Analysis]
377 Xu S, Wang Y, Tai DC, Wang S, Cheng CL, Peng Q, Yan J, Chen Y, Sun J, Liang X. qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol. 2014;61:260-269. [PMID: 24583249 DOI: 10.1016/j.jhep.2014.02.015] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 11.7] [Reference Citation Analysis]
378 Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. Scand J Clin Lab Invest. 2014;74:240-247. [PMID: 24460024 DOI: 10.3109/00365513.2013.879392] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
379 Wang L, Yao M, Liu S, Yang D, Wen X, Ning J, Wang L, Zhou G, Xu Q, Chen X, Zhao J, Lu F. Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis. Dis Markers 2020;2020:6036904. [PMID: 32089754 DOI: 10.1155/2020/6036904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
380 Alboraie M, Khairy M, Elsharkawy M, Asem N, Elsharkawy A, Esmat G. Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus. Hepatol Res. 2014; Jul 3. [Epub ahead of print]. [PMID: 24995544 DOI: 10.1111/hepr.12385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
381 Schiavon LL, Carvalho-filho RJ, Narciso-schiavon JL, Medina-pestana JO, Lanzoni VP, Ferraz MLG, Silva AEB. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection. Scandinavian Journal of Gastroenterology 2010;45:615-22. [DOI: 10.3109/00365521003637203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
382 Takemoto R, Nakamuta M, Aoyagi Y, Fujino T, Yasutake K, Koga K, Yoshimoto T, Miyahara T, Fukuizumi K, Wada Y. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection. J Dig Dis. 2009;10:145-148. [PMID: 19426398 DOI: 10.1111/j.1751-2980.2009.00377.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
383 Castiella A, Zapata E, Alústiza JM. Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond. World J Hepatol 2010; 2(7): 251-255 [PMID: 21161006 DOI: 10.4254/wjh.v2.i7.251] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
384 Venkatesh SK, Ehman RL. Magnetic resonance elastography of liver. Magn Reson Imaging Clin N Am. 2014;22:433-446. [PMID: 25086938 DOI: 10.1016/j.mric.2014.05.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 16.7] [Reference Citation Analysis]
385 Chamarthi SK, Raterman B, Mazumder R, Michaels A, Oza VM, Hanje J, Bolster B, Jin N, White RD, Kolipaka A. Rapid acquisition technique for MR elastography of the liver. Magn Reson Imaging. 2014;32:679-683. [PMID: 24637083 DOI: 10.1016/j.mri.2014.02.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
386 Wu KL, Chen YL, Ko CJ, Lin PY, Chou CT. Comparison of the diagnostic performance of magnetic resonance elastography and Wisteria foribunda agglutinin-positive Mac-2-binding protein in the determination of advanced liver fibrosis stages in patients with chronic liver disease. Exp Ther Med 2020;20:1953-60. [PMID: 32782504 DOI: 10.3892/etm.2020.8922] [Reference Citation Analysis]
387 Cholongitas E, Quaglia A, Samonakis D, Mela M, Patch D, Dhillon AP, Fanshawe TR, Burroughs AK. Transjugular liver biopsy in patients with diffuse liver disease: comparison of three cores with one or two cores for accurate histological interpretation. Liver Int 2007;27:646-53. [DOI: 10.1111/j.1478-3231.2007.01496.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
388 Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE. Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol 2012;19:250-62. [PMID: 22692288 DOI: 10.1097/PAP.0b013e31825c6a20] [Cited by in Crossref: 70] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
389 Lionetti R, Tisone G, Palmieri G, Almerighi C, Anselmo A, Tariciotti L, Lenci I, De Luca L, Monaco A, Angelico M. Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression. Dig Liver Dis. 2010;42:297-303. [PMID: 19818696 DOI: 10.1016/j.dld.2009.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
390 de Lédinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J Hepatol. 2006;45:592-599. [PMID: 16837098 DOI: 10.1016/j.jhep.2006.05.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
391 Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G. Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology 2012;55:1146-53. [PMID: 22109744 DOI: 10.1002/hep.24805] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
392 Motosugi U, Hernando D, Bannas P, Holmes JH, Wang K, Shimakawa A, Iwadate Y, Taviani V, Rehm JL, Reeder SB. Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI. J Magn Reson Imaging 2015;42:1241-8. [PMID: 25828696 DOI: 10.1002/jmri.24896] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
393 Zeremski M, Talal AH. Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients? Journal of Hepatology 2005;43:2-5. [DOI: 10.1016/j.jhep.2005.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
394 Kumar M, Kumar A, Hissar S, Jain P, Rastogi A, Kumar D, Sakhuja P, Sarin SK. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int. 2008;28:690-698. [PMID: 18433395 DOI: 10.1111/j.1478-3231.2008.01711.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
395 Dang HW, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Park YN, Choi EH, Kim DY. How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements. Yonsei Med J. 2012;53:337-345. [PMID: 22318821 DOI: 10.3349/2012.53.2.337] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
396 Bi Y, Venkatesh SK, Shah VH. Detecting fibrosis without a liver biopsy: getting to the fat of the issue. Hepatol Int 2013;7:792-4. [PMID: 26201914 DOI: 10.1007/s12072-013-9450-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
397 Schwen LO, Preusser T. Analysis and algorithmic generation of hepatic vascular systems. Int J Hepatol 2012;2012:357687. [PMID: 23056953 DOI: 10.1155/2012/357687] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
398 Ogawa Y, Imajo K, Yoneda M, Kessoku T, Tomeno W, Shinohara Y, Kato S, Mawatari H, Nozaki Y, Fujita K, Kirikoshi H, Maeda S, Saito S, Wada K, Nakajima A. Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis. PLoS One 2013;8:e65211. [PMID: 23762319 DOI: 10.1371/journal.pone.0065211] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
399 Daniel S. Chronic Hepatitis C Treatment Patterns in African American Patients: An Update. Am J Gastroenterol 2005;100:716-22. [DOI: 10.1111/j.1572-0241.2005.41321.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
400 Fuchs BC, Wang H, Yang Y, Wei L, Polasek M, Schühle DT, Lauwers GY, Parkar A, Sinskey AJ, Tanabe KK, Caravan P. Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol 2013;59:992-8. [PMID: 23838178 DOI: 10.1016/j.jhep.2013.06.026] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 11.8] [Reference Citation Analysis]
401 Yun MH, Seo YS, Kang HS, Lee KG, Kim JH, An H, Yim HJ, Keum B, Jeen YT, Lee HS. The effect of the respiratory cycle on liver stiffness values as measured by transient elastography. J Viral Hepat. 2011;18:631-636. [PMID: 21029256 DOI: 10.1111/j.1365-2893.2010.01376.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
402 Guo L, Li W, Hu L, Zhou H, Zheng L, Yu L, Liang W. Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis. Oncotarget. 2018;9:5397-5405. [PMID: 29435187 DOI: 10.18632/oncotarget.23332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
403 Talwalkar JA. Elastography for detecting hepatic fibrosis: options and considerations. Gastroenterology. 2008;135:299-302. [PMID: 18555023 DOI: 10.1053/j.gastro.2008.05.038] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
404 Nelson DR, Davis GL, Jacobson I, Everson GT, Fried MW, Harrison SA, Hassanein T, Jensen DM, Lindsay KL, Terrault N, Zein N. Hepatitis C virus: a critical appraisal of approaches to therapy. Clin Gastroenterol Hepatol 2009;7:397-414; quiz 366. [PMID: 19114127 DOI: 10.1016/j.cgh.2008.11.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
405 Afdhal NH, Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol. 2007;46:543-545. [PMID: 17316879 DOI: 10.1016/j.jhep.2007.01.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
406 Dhyani M, Anvari A, Samir AE. Ultrasound elastography: liver. Abdom Imaging 2015;40:698-708. [PMID: 25690689 DOI: 10.1007/s00261-015-0373-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
407 Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky J, Mchutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. Journal of Hepatology 2004;41:935-42. [DOI: 10.1016/j.jhep.2004.08.008] [Cited by in Crossref: 231] [Cited by in F6Publishing: 216] [Article Influence: 13.6] [Reference Citation Analysis]
408 Ratziu V, Bugianesi E, Dixon J, Fassio E, Ekstedt M, Charlotte F, Kechagias S, Poynard T, Olsson R. Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. Aliment Pharmacol Ther 2007;26:821-30. [PMID: 17767466 DOI: 10.1111/j.1365-2036.2007.03425.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
409 Friedrich-Rust M, Romen D, Vermehren J, Kriener S, Sadet D, Herrmann E, Zeuzem S, Bojunga J. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol. 2012;81:e325-e331. [PMID: 22119555 DOI: 10.1016/j.ejrad.2011.10.029] [Cited by in Crossref: 129] [Cited by in F6Publishing: 117] [Article Influence: 12.9] [Reference Citation Analysis]
410 Suda T, Okawa O, Masaoka R, Gyotoku Y, Tokutomi N, Katayama Y, Tamano M. Shear wave elastography in hepatitis C patients before and after antiviral therapy. World J Hepatol 2017; 9(1): 64-68 [PMID: 28105260 DOI: 10.4254/wjh.v9.i1.64] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
411 Morse CG, McLaughlin M, Proschan M, Koh C, Kleiner DE, Heller T, Kovacs JA. Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy. AIDS 2015;29:2297-302. [PMID: 26544701 DOI: 10.1097/QAD.0000000000000841] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 5.6] [Reference Citation Analysis]
412 Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Lenaour G, Vaillant JC. Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C. Clin Res Hepatol Gastroenterol. 2012;36:455-463. [PMID: 22959098 DOI: 10.1016/j.clinre.2012.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
413 Nguyen-khac E, Capron D, Castelain S, François C, Braillon A. Personalized therapy for chronic viral hepatitis C in the naive patient: How can we optimize treatment duration as a function of viral genotype? European Journal of Internal Medicine 2007;18:510-5. [DOI: 10.1016/j.ejim.2007.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
414 Munteanu M, Ratziu V, Poynard T. FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted. J Hepatol 2011;55:233; author reply 234-5. [PMID: 21295091 DOI: 10.1016/j.jhep.2011.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
415 Nakajima M, Kobayashi S, Wada H, Tomokuni A, Takahashi H, Noda T, Matsui H, Matsukuma S, Kanekiyo S, Shindo Y, Tokumitsu Y, Nakagami Y, Suzuki N, Takeda S, Tanabe M, Ito K, Hoshii Y, Eguchi H, Nagano H. Viral elimination is essential for improving surgical outcomes of hepatitis C virus-related hepatocellular carcinoma: Multicenter retrospective analysis. Ann Gastroenterol Surg 2020;4:710-20. [PMID: 33319162 DOI: 10.1002/ags3.12377] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 Purvis LAB, Clarke WT, Valkovič L, Levick C, Pavlides M, Barnes E, Cobbold JF, Robson MD, Rodgers CT. Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla. Magn Reson Med 2017;78:2095-105. [PMID: 28244131 DOI: 10.1002/mrm.26635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
417 Kobayashi K, Nakao H, Nishiyama T, Lin Y, Kikuchi S, Kobayashi Y, Yamamoto T, Ishii N, Ohashi T, Satoh K. Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis: a meta-analysis. Eur Radiol. 2015;25:230-238. [PMID: 25149296 DOI: 10.1007/s00330-014-3364-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
418 Shin NY, Kim MJ, Lee MJ, Han SJ, Koh H, Namgung R, Park YN. Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia. J Ultrasound Med. 2014;33:853-864. [PMID: 24764341 DOI: 10.7863/ultra.33.5.853] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
419 Friedrich-Rust M, Buggisch P, de Knegt RJ, Dries V, Shi Y, Matschenz K, Schneider MD, Herrmann E, Petersen J, Schulze F, Zeuzem S, Sarrazin C. Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat. 2013;20:240-247. [PMID: 23490368 DOI: 10.1111/j.1365-2893.2012.01646.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
420 Trépo E, Potthoff A, Pradat P, Bakshi R, Young B, Lagier R, Moreno C, Verset L, Cross R, Degré D. Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease. J Hepatol. 2011;55:38-44. [PMID: 21145859 DOI: 10.1016/j.jhep.2010.10.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
421 Laharie D, Zerbib F, Adhoute X, Boué-Lahorgue X, Foucher J, Castéra L, Rullier A, Bertet J, Couzigou P, Amouretti M, de Lédinghen V. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. Aliment Pharmacol Ther 2006;23:1621-8. [PMID: 16696812 DOI: 10.1111/j.1365-2036.2006.02929.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
422 Parkes J, Guha IN, Roderick P, Harris S, Cross R, Manos MM, Irving W, Zaitoun A, Wheatley M, Ryder S. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat. 2011;18:23-31. [PMID: 20196799 DOI: 10.1111/j.1365-2893.2009.01263.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 10.8] [Reference Citation Analysis]
423 Kalantari H, Hoseini H, Babak A, Yaran M. Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection. Hepat Res Treat. 2011;2011:972759. [PMID: 22254137 DOI: 10.1155/2011/972759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
424 Ajmera VH, Liu A, Singh S, Yachoa G, Ramey M, Bhargava M, Zamani A, Lopez S, Mangla N, Bettencourt R, Rizo E, Valasek M, Behling C, Richards L, Sirlin C, Loomba R. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease. Hepatology. 2020;71:849-860. [PMID: 31556124 DOI: 10.1002/hep.30974] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 22.0] [Reference Citation Analysis]
425 Jiang Z, Yamauchi K, Yoshioka K, Aoki K, Kuroyanagi S, Iwata A, Yang J, Wang K. Support Vector Machine-Based Feature Selection for Classification of Liver Fibrosis Grade in Chronic Hepatitis C. J Med Syst 2006;30:389-94. [DOI: 10.1007/s10916-006-9023-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
426 Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol. 2005;43:78-84. [PMID: 15894397 DOI: 10.1016/j.jhep.2005.02.025] [Cited by in Crossref: 153] [Cited by in F6Publishing: 133] [Article Influence: 9.6] [Reference Citation Analysis]
427 Kumagi T, Onji M. Presentation and diagnosis of primary biliary cirrhosis in the 21st century. Clin Liver Dis 2008;12:243-59; vii. [PMID: 18456178 DOI: 10.1016/j.cld.2008.02.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
428 García-Jurado L, Oyagüez I, Casado MÁ, Tural C, González-García J, Ortega E, Pineda JA. [Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus]. Enferm Infecc Microbiol Clin. 2012;30:294-299. [PMID: 22197275 DOI: 10.1016/j.eimc.2011.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
429 Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011;5:625-634. [PMID: 21484142 DOI: 10.1007/s12072-010-9240-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
430 Poterucha JT, Johnson JN, Qureshi MY, O'Leary PW, Kamath PS, Lennon RJ, Bonnichsen CR, Young PM, Venkatesh SK, Ehman RL, Gupta S, Smyrk TC, Dearani JA, Warnes CA, Cetta F. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation. Mayo Clin Proc. 2015;90:882-894. [PMID: 26059757 DOI: 10.1016/j.mayocp.2015.04.020] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
431 Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12(23): 3682-3694 [PMID: 16773685 DOI: 10.3748/wjg.v12.i23.3682] [Cited by in CrossRef: 174] [Cited by in F6Publishing: 165] [Article Influence: 11.6] [Reference Citation Analysis]
432 Friedrich-rust M, Hadji-hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, Zeuzem S, Bojunga J. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol 2010;20:2390-6. [DOI: 10.1007/s00330-010-1820-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
433 Runge JH, van der Kemp WJ, Klomp DW, Luijten PR, Nederveen AJ, Stoker J. 2D AMESING multi-echo (31)P-MRSI of the liver at 7T allows transverse relaxation assessment and T2-weighted averaging for improved SNR. Magn Reson Imaging 2016;34:219-26. [PMID: 26597833 DOI: 10.1016/j.mri.2015.10.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
434 Shaheen AAM, Myers RP. Systematic Review and Meta–Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection. HIV Clinical Trials 2015;9:43-51. [DOI: 10.1310/hct0901-43] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
435 Kim DY, Kim SU, Ahn SH, Park JY, Lee JM, Park YN, Yoon KT, Paik YH, Lee KS, Chon CY, Han KH. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci. 2009;54:1758-1763. [PMID: 19005758 DOI: 10.1007/s10620-008-0541-2] [Cited by in Crossref: 90] [Cited by in F6Publishing: 101] [Article Influence: 6.9] [Reference Citation Analysis]
436 Kim JE, Lee JY, Kim YJ, Yoon JH, Kim SH, Lee JM, Han JK, Choi BI. Acoustic radiation force impulse elastography for chronic liver disease: comparison with ultrasound-based scores of experienced radiologists, Child-Pugh scores and liver function tests. Ultrasound Med Biol. 2010;36:1637-1643. [PMID: 20800940 DOI: 10.1016/j.ultrasmedbio.2010.07.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
437 Chen G, Jiang J, Wang X, Yang M, Xie Y, Guo H, Tang H, Zhou L, Hu D, Kamel IR, Chen Z, Li Z. Evaluation of hepatic steatosis before liver transplantation in ex vivo by volumetric quantitative PDFF-MRI. Magn Reson Med 2021;85:2805-14. [PMID: 33197060 DOI: 10.1002/mrm.28592] [Reference Citation Analysis]
438 Hadefi A, Degré D, Trépo E, Moreno C. Noninvasive diagnosis in alcohol-related liver disease. Health Sci Rep 2020;3:e146. [PMID: 32166191 DOI: 10.1002/hsr2.146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
439 Okamura Y, Ashida R, Yamamoto Y, Ito T, Sugiura T, Bekku E, Aramaki T, Uesaka K. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery. Langenbecks Arch Surg 2016;401:195-203. [PMID: 26943655 DOI: 10.1007/s00423-016-1389-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
440 Sun W, Chang S, Tai DC, Tan N, Xiao G, Tang H, Yu H. Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies. J Biomed Opt 2008;13:064010. [PMID: 19123657 DOI: 10.1117/1.3041159] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
441 Vallet-pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-venier V, Fontaine H, Pol S. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-6. [DOI: 10.1002/hep.21669] [Cited by in Crossref: 1026] [Cited by in F6Publishing: 982] [Article Influence: 73.3] [Reference Citation Analysis]
442 Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair 2012;5:1. [PMID: 22214245 DOI: 10.1186/1755-1536-5-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
443 De Sanctis V, Soliman AT, Daar S, Alansary N, Kattamis A, Skafida M, Galati MC, Christou S, Campisi S, Messina G, Yassin MA, Canatan D, Di Maio S, Al Jaouni S, Raiola G, Karimi M, Kaleva V, Kakkar S, Mariannis D, Kattamis C. A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience. Mediterr J Hematol Infect Dis 2020;12:e2020006. [PMID: 31934316 DOI: 10.4084/MJHID.2020.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
444 Zarski J, Bedossa P, Bronowicki J, Doffoel M, Poynard T. Utilisation des marqueurs non invasifs de fibrose dans la prise en charge de l’hépatite C. Gastroentérologie Clinique et Biologique 2007;31:34-9. [DOI: 10.1016/s0399-8320(07)92561-0] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
445 Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L, Yu D, Han Y, Zhang D, Chen P, Zhang X, Yuan Z, Huang J, Zhang X. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep 2017;7:43446. [PMID: 28262670 DOI: 10.1038/srep43446] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
446 Rocha HLOG, Diniz ALD, Borges VFDAE, Salomão FC. Assessment of portal venous index as a non-invasive method for diagnosing liver fibrosis in patients with chronic hepatitis C. Arq Gastroenterol 2012;49:14-8. [DOI: 10.1590/s0004-28032012000100004] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
447 Kim YW, Kwon JH, Jang JW, Kim MJ, Oh BS, Chung KW, Park ES, Nam SW. Diagnostic usefulness of real-time elastography for liver fibrosis in chronic viral hepatitis B and C. Gastroenterol Res Pract 2014;2014:210407. [PMID: 25180031 DOI: 10.1155/2014/210407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
448 Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, de Lédinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50. [DOI: 10.1053/j.gastro.2004.11.018] [Cited by in Crossref: 1666] [Cited by in F6Publishing: 1579] [Article Influence: 104.1] [Reference Citation Analysis]
449 Zhang CY, Zhang Q, Zhang HM, Yang HS. 3.0T 31P MR spectroscopy in assessment of response to antiviral therapy for chronic hepatitis C. World J Gastroenterol 2014; 20(8): 2107-2112 [PMID: 24587683 DOI: 10.3748/wjg.v20.i8.2107] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
450 Schulman AR, Lin MV, Rutherford A, Chan WW, Ryou M. A Prospective Blinded Study of Endoscopic Ultrasound Elastography in Liver Disease: Towards a Virtual Biopsy. Clin Endosc 2018;51:181-5. [PMID: 29566479 DOI: 10.5946/ce.2017.095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
451 Teixeira R, Marcos LA, Friedman SL. Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C. Hepatology Research 2007;37:579-95. [DOI: 10.1111/j.1872-034x.2007.00085.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
452 Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V. Assessment of liver fibrosis: noninvasive means. Saudi J Gastroenterol. 2008;14:163-173. [PMID: 19568532 DOI: 10.4103/1319-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
453 Norén B, Forsgren MF, Dahlqvist Leinhard O, Dahlström N, Kihlberg J, Romu T, Kechagias S, Almer S, Smedby Ö, Lundberg P. Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Eur Radiol. 2013;23:174-181. [PMID: 22836161 DOI: 10.1007/s00330-012-2583-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
454 Jeong JY, Cho YS, Sohn JH. Role of two-dimensional shear wave elastography in chronic liver diseases: A narrative review. World J Gastroenterol 2018; 24(34): 3849-3860 [PMID: 30228779 DOI: 10.3748/wjg.v24.i34.3849] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
455 Goodman ZD, Becker RL, Pockros PJ, Afdhal NH. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology. 2007;45:886-894. [PMID: 17393526 DOI: 10.1002/hep.21595] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 7.9] [Reference Citation Analysis]
456 Feng JC, Li J, Wu XW, Peng XY. Diagnostic Accuracy of SuperSonic Shear Imaging for Staging of Liver Fibrosis: A Meta-analysis. J Ultrasound Med 2016;35:329-39. [PMID: 26795041 DOI: 10.7863/ultra.15.03032] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
457 Keller J, Kaltenbach TE, Haenle MM, Oeztuerk S, Graeter T, Mason RA, Seufferlein T, Kratzer W. Comparison of Acoustic Structure Quantification (ASQ), shearwave elastography and histology in patients with diffuse hepatopathies. BMC Med Imaging. 2015;15:58. [PMID: 26637242 DOI: 10.1186/s12880-015-0100-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
458 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1056/s0140-6736(08)60383-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
459 Kim SU, Seo YS, Cheong JY, Kim MY, Kim JK, Um SH, Cho SW, Paik SK, Lee KS, Han KH. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2010;32:498-505. [PMID: 20491742 DOI: 10.1111/j.1365-2036.2010.04353.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
460 Tsochatzis EA, Castera L. Assessing liver disease in HIV–HCV coinfected patients: . Current Opinion in HIV and AIDS 2015;10:316-22. [DOI: 10.1097/coh.0000000000000176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
461 Roy S, Majumder A. A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy. Cureus 2019;11:e4674. [PMID: 31328066 DOI: 10.7759/cureus.4674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
462 Nishio T, Taura K, Koyama Y, Tanabe K, Yamamoto G, Okuda Y, Ikeno Y, Seo S, Yasuchika K, Hatano E, Okajima H, Kaido T, Tanaka S, Uemoto S. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma. Surgery 2016;159:399-408. [DOI: 10.1016/j.surg.2015.06.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
463 Gressner AM, Gao CF, Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: A short survey. World J Gastroenterol 2009; 15(20): 2433-2440 [PMID: 19468990 DOI: 10.3748/wjg.15.2433] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
464 Yen YH, Kuo FY, Kee KM, Chang KC, Tsai MC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH. APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level. PLoS One. 2018;13:e0199760. [PMID: 29953518 DOI: 10.1371/journal.pone.0199760] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
465 Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, Mela M, Manousou P, Senzolo M, Dhillon AP, Patch D, Burroughs AK. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis. Liver Transpl 2007;13:1305-11. [PMID: 17763383 DOI: 10.1002/lt.21227] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
466 Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, Henderson WC, Wang K, Andre MP, Samir AE, Sirlin CB. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging 2020;51:25-42. [PMID: 30859677 DOI: 10.1002/jmri.26716] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
467 Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol. 2011;54:650-659. [PMID: 21146892 DOI: 10.1016/j.jhep.2010.07.033] [Cited by in Crossref: 445] [Cited by in F6Publishing: 403] [Article Influence: 40.5] [Reference Citation Analysis]
468 Chou CT, Chen RC, Wu WP, Lin PY, Chen YL. Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma. Ultrasound Med Biol. 2017;43:2783-2790. [PMID: 28965721 DOI: 10.1016/j.ultrasmedbio.2017.08.1879] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
469 Akima T, Tamano M, Hiraishi H. Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis. Hepatol Res. 2011;41:965-970. [PMID: 21883739 DOI: 10.1111/j.1872-034x.2011.00846.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
470 Wahl K, Rosenberg W, Vaske B, Manns MP, Schulze-Osthoff K, Bahr MJ, Bantel H. Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography. PLoS One 2012;7:e51906. [PMID: 23284811 DOI: 10.1371/journal.pone.0051906] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
471 Ganne-carrié N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, Dhumeaux D, Trinchet J, Beaugrand M. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-7. [DOI: 10.1002/hep.21420] [Cited by in Crossref: 349] [Cited by in F6Publishing: 343] [Article Influence: 23.3] [Reference Citation Analysis]
472 Suda T, Kanefuji T, Abe A, Nagayama I, Hoshi T, Morita S, Yagi K, Hatakeyama S, Hayatsu M, Hasegawa N, Terai S. A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates. Medicine (Baltimore) 2019;98:e13958. [PMID: 30633176 DOI: 10.1097/MD.0000000000013958] [Reference Citation Analysis]
473 Fang C, Virdee S, Jacob J, Rufai O, Agarwal K, Quaglia A, Quinlan DJ, Sidhu PS. Strain elastography for noninvasive assessment of liver fibrosis: A prospective study with histological comparison. Ultrasound 2019;27:262-71. [PMID: 31762783 DOI: 10.1177/1742271X19862836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
474 Alessandria C, Debernardi-venon W, Rizzetto M, Marzano A. Transjugular liver biopsy: A relatively simple procedure with an indefinite past and an expected brilliant future. Journal of Hepatology 2008;48:171-2. [DOI: 10.1016/j.jhep.2007.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
475 Gu J, Zhang E, Liang B, Zhang Z, Chen X, Huang Z. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function. World J Surg Oncol 2020;18:79. [PMID: 32326968 DOI: 10.1186/s12957-020-01854-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
476 Rosenthal-allieri MA, Tran A, Halfon P, Imbert-bismut F, Munteanu M, Messous D, Peritore M, Poynard T, Bernard A. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C. Gastroentérologie Clinique et Biologique 2007;31:815-21. [DOI: 10.1016/s0399-8320(07)73971-4] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
477 Bohte AE, Garteiser P, De Niet A, Groot PF, Sinkus R, Stoker J, Nederveen AJ. MR elastography of the liver: defining thresholds for detecting viscoelastic changes. Radiology. 2013;269:768-776. [PMID: 23824991 DOI: 10.1148/radiol.13122669] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
478 Thuluvath PJ, Krok KL. Noninvasive Markers of Fibrosis for Longitudinal Assessment of Fibrosis in Chronic Liver Disease: Are They Ready for Prime Time? Am J Gastroenterol 2006;101:1497-9. [DOI: 10.1111/j.1572-0241.2005.00304.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
479 Martyn-simmons C, Rosenberg W, Cross R, Wong T, Smith C, Barker J. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study. Br J Dermatol 2014;171:267-73. [DOI: 10.1111/bjd.12782] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
480 Dolmazashvili E, Abutidze A, Chkhartishvili N, Karchava M, Sharvadze L, Tsertsvadze T. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience. Eur J Gastroenterol Hepatol 2017;29:1223-30. [PMID: 28857900 DOI: 10.1097/MEG.0000000000000964] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 14.3] [Reference Citation Analysis]
481 Lefebvre T, Petitclerc L, Hébert M, Bilodeau L, Sebastiani G, Olivié D, Gao ZH, Sylvestre MP, Cloutier G, Nguyen BN, Gilbert G, Tang A. MRI cine-tagging of cardiac-induced motion for noninvasive staging of liver fibrosis. J Magn Reson Imaging 2020;51:1570-80. [PMID: 31605412 DOI: 10.1002/jmri.26935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
482 Kang JK, Cheong JY, Cho SW, Cho JH, Park JS, Kim YB, Kim DJ, Hwang SG, Yang JM, Park YN. Liver stiffness measurement for the diagnosis of hepatic fibrosis in patients with chronic viral hepatitis. Korean J Hepatol. 2007;13:521-529. [PMID: 18159150 DOI: 10.3350/kjhep.2007.13.4.521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
483 Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C; HALT-C Trial Group. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology 2005;42:282-92. [DOI: 10.1002/hep.20772] [Cited by in Crossref: 222] [Cited by in F6Publishing: 207] [Article Influence: 13.9] [Reference Citation Analysis]
484 Crespo G, Forns X, Navasa M. [Serum markers of liver fibrosis in patients with chronic hepatitis C infection. Prognostic value of noninvasive markers of fibrosis in liver transplantation]. Gastroenterol Hepatol 2012;35 Suppl 2:17-22. [PMID: 23298655 DOI: 10.1016/S0210-5705(12)70045-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
485 Kwong GA, von Maltzahn G, Murugappan G, Abudayyeh O, Mo S, Papayannopoulos IA, Sverdlov DY, Liu SB, Warren AD, Popov Y, Schuppan D, Bhatia SN. Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol 2013;31:63-70. [PMID: 23242163 DOI: 10.1038/nbt.2464] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 12.9] [Reference Citation Analysis]
486 Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH. Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. Clin Gastroenterol Hepatol. 2008;6:1403-1411. [PMID: 19081528 DOI: 10.1016/j.cgh.2008.08.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
487 Afdhal NH, Manning D. Diagnosis of liver fibrosis in 2008 and beyond. Gastroenterol Clin Biol. 2008;32:88-90. [PMID: 18973851 DOI: 10.1016/s0399-8320(08)73998-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
488 Lee M, Keeffe EB. Hepatitis B: modern end points of treatment and the specter of viral resistance. Gastroenterol Clin North Am. 2011;40:495-505. [PMID: 21893270 DOI: 10.1016/j.gtc.2011.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
489 Wong VW, Lampertico P, de Lédinghen V, Chang PE, Kim SU, Chen Y, Chan HL, Mangia G, Foucher J, Chow WC, Ahn SH, Hou J. Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients. Dig Dis Sci 2015;60:1448-56. [DOI: 10.1007/s10620-014-3488-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
490 Calle-Toro JS, Serai SD, Hartung EA, Goldberg DJ, Bolster BD Jr, Darge K, Anupindi SA. Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease. Abdom Radiol (NY) 2019;44:894-902. [PMID: 30600386 DOI: 10.1007/s00261-018-1884-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
491 Barker J, Horn EJ, Lebwohl M, Warren RB, Nast A, Rosenberg W, Smith C. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic. J Eur Acad Dermatol Venereol. 2011;25:758-764. [PMID: 21198946 DOI: 10.1111/j.1468-3083.2010.03932.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
492 Xie C, Ma B, Wang N, Wan L. Comparison of serological assessments in the diagnosis of liver fibrosis in bile duct ligation mice. Exp Biol Med (Maywood) 2017;242:1398-404. [PMID: 28669222 DOI: 10.1177/1535370217718179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
493 Gleeson FC, Clayton AC, Zhang L, Clain JE, Gores GJ, Rajan E, Smyrk TC, Topazian MD, Wang KK, Wiersema MJ, Levy MJ. Adequacy of endoscopic ultrasound core needle biopsy specimen of nonmalignant hepatic parenchymal disease. Clin Gastroenterol Hepatol 2008;6:1437-40. [PMID: 19081532 DOI: 10.1016/j.cgh.2008.07.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
494 Tajiri K, Kawai K, Sugiyama T. Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases. J Gastroenterol 2017;52:724-33. [PMID: 27787686 DOI: 10.1007/s00535-016-1277-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
495 Rockstroh JK. Hot topics in HIV and hepatitis coinfection: noninvasive diagnosis of liver disease, liver transplantation, and new drugs for treatment of hepatitis coinfection. HIV Clin Trials 2009;10:110-5. [PMID: 19487181 DOI: 10.1310/hct1002-110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
496 Asselah T, Lada O, Boyer N, Martinot M, Marcellin P. [Treatment of chronic hepatitis B]. Gastroenterol Clin Biol. 2008;32:749-768. [PMID: 18775613 DOI: 10.1016/j.gcb.2008.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
497 Ou H, Bonekamp S, Bonekamp D, Corona-villalobos CP, Torbenson MS, Geiger B, Kamel IR. MRI Arterial Enhancement Fraction in Hepatic Fibrosis and Cirrhosis. American Journal of Roentgenology 2013;201:W596-602. [DOI: 10.2214/ajr.12.10048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
498 Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis. Hepatol Res 2015;45:1083-90. [PMID: 25565570 DOI: 10.1111/hepr.12473] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
499 Bekçibaşı M, Deveci Ö, Oğuz A, Bozkurt F, Dayan S, Çelen MK. Serum TNF-α, IL-1β, and IL-6 levels in chronic HBV-infected patients. Int J Clin Pract 2021;75:e14292. [PMID: 33930244 DOI: 10.1111/ijcp.14292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
500 Jian ZC, Long JF, Liu YJ, Hu XD, Liu JB, Shi XQ, Li WS, Qian LX. Diagnostic value of two dimensional shear wave elastography combined with texture analysis in early liver fibrosis. World J Clin Cases 2019; 7(10): 1122-1132 [PMID: 31183343 DOI: 10.12998/wjcc.v7.i10.1122] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
501 Jeong JY, Kim TY, Sohn JH, Kim Y, Jeong WK, Oh YH, Yoo KS. Real time shear wave elastography in chronic liver diseases: Accuracy for predicting liver fibrosis, in comparison with serum markers. World J Gastroenterol 2014; 20(38): 13920-13929 [PMID: 25320528 DOI: 10.3748/wjg.v20.i38.13920] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
502 Vasel M, Rutz R, Bersch C, Feick P, Singer MV, Kirschfink M, Nakchbandi IA. Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C. Clin Immunol 2014;150:149-56. [PMID: 24412908 DOI: 10.1016/j.clim.2013.11.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
503 Gao S, Li XY, Fan YC, Sun FK, Han LY, Li F, Ji XF, Wang K. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal. J Gastroenterol Hepatol 2017;32:215-20. [PMID: 27207016 DOI: 10.1111/jgh.13452] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
504 Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat. 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
505 Chang PE, Goh GBB, Leow WQ, Shen L, Lim KH, Tan CK. Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease. PLoS One 2018;13:e0199166. [PMID: 29924825 DOI: 10.1371/journal.pone.0199166] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
506 Takeda T, Yasuda T, Nakayama Y, Nakaya M, Kimura M, Yamashita M, Sawada A, Abo K, Takeda S, Sakaguchi H, Shiomi S, Asai H, Seki S. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 2006; 12(48): 7768-7773 [PMID: 17203518 DOI: 10.3748/wjg.v12.i48.7768] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
507 Carlson JJ, Kowdley KV, Sullivan SD, Ramsey SD, Veenstra DL. An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol 2009;24:786-91. [PMID: 19457153 DOI: 10.1111/j.1440-1746.2009.05778.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
508 Carrión JA, Navasa M, Buti M, Torras X, Xiol X, Vergara M, Planas R, Solà R, Forns X. Elastografía hepática. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2011;34:504-10. [DOI: 10.1016/j.gastrohep.2011.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
509 Kasai Y, Moriyasu F, Saito K, Hara T, Kobayashi Y, Nakamura I, Sugimoto K. Value of shear wave elastography for predicting hepatocellular carcinoma and esophagogastric varices in patients with chronic liver disease. J Med Ultrason (2001) 2015;42:349-55. [PMID: 26576786 DOI: 10.1007/s10396-014-0603-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
510 Pavlov CS, Casazza G, Semenistaia M, Nikolova D, Tsochatzis E, Liusina E, Ivashkin VT, Gluud C. Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev. 2016;3:CD011602. [PMID: 26934429 DOI: 10.1002/14651858.cd011602.pub2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
511 Snyder N, Gajula L, Xiao SY, Grady J, Luxon B, Lau DT, Soloway R, Petersen J. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol. 2006;40:535-542. [PMID: 16825937 DOI: 10.1097/00004836-200607000-00013] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
512 Clark TW, McCann JW, Salsamendi J, Dowd MF, Hajdu CH. Optimizing needle direction during transjugular liver biopsy provides superior biopsy specimens. Cardiovasc Intervent Radiol 2014;37:1540-5. [PMID: 24352863 DOI: 10.1007/s00270-013-0819-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
513 Lee CK, Nastasio S, Mitchell PD, Fawaz R, Elisofon SA, Vakili K, Kim HB, Nguyen D, Jonas MM. Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients. Pediatr Transplant 2020;24:e13736. [PMID: 32432836 DOI: 10.1111/petr.13736] [Reference Citation Analysis]
514 Du H, Yu H, Yang Y, Song Y, Wang F, Li S, Jiang Y. Computational identification of microRNAs and their targets in liver cirrhosis. Oncol Lett 2017;14:7691-8. [PMID: 29250171 DOI: 10.3892/ol.2017.7252] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
515 Wong GLH. Transient elastography: Kill two birds with one stone? World J Hepatol 2013; 5(5): 264-274 [PMID: 23717737 DOI: 10.4254/wjh.v5.i5.264] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 7.4] [Reference Citation Analysis]
516 Romero Gómez M, Martín del Campo MR, Ángeles Otero M, Vallejo M, Corpas R, Castellano-megías VM. Estudio comparativo de dos modelos que utilizan parámetros bioquímicos en el diagnóstico no invasivo de la fibrosis hepática en pacientes con hepatitis C. Medicina Clínica 2005;124:761-4. [DOI: 10.1157/13075845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
517 Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005;4:10. [PMID: 16375767 DOI: 10.1186/1476-5926-4-10] [Cited by in Crossref: 201] [Cited by in F6Publishing: 195] [Article Influence: 12.6] [Reference Citation Analysis]
518 Chen YP, Liang XE, Dai L, Zhang Q, Peng J, Zhu YF, Wen WQ, Chan HL, Hou JL. Improving transient elastography performance for detecting hepatitis B cirrhosis. Digestive and Liver Disease 2012;44:61-6. [DOI: 10.1016/j.dld.2011.08.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
519 Gleeson FC, Levy MJ. EUS Trucut biopsy liver parenchyma acquisition and yield are comparable to that of a transjugular liver biopsy. Gastrointest Endosc. 2009;70:1046; author reply 1046-1046; author reply 1047. [PMID: 19879410 DOI: 10.1016/j.gie.2009.03.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
520 Jeong WK, Lim HK, Lee HK, Jo JM, Kim Y. Principles and clinical application of ultrasound elastography for diffuse liver disease. Ultrasonography 2014;33:149-60. [PMID: 25038804 DOI: 10.14366/usg.14003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 11.4] [Reference Citation Analysis]
521 Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C. Altered serum N-glycomics in chronic hepatitis B patients. Liver Int. 2010;30:259-267. [PMID: 19951379 DOI: 10.1111/j.1478-3231.2009.02170.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
522 Tamaki N, Kurosaki M, Matsuda S, Nakata T, Muraoka M, Suzuki Y, Yasui Y, Suzuki S, Hosokawa T, Nishimura T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Matsunaga K, Taki K, Asahina Y, Izumi N. Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients. Hepatol Res. 2014;44:720-727. [PMID: 23742243 DOI: 10.1111/hepr.12179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
523 Motosugi U, Hernando D, Wiens C, Bannas P, Reeder SB. High SNR Acquisitions Improve the Repeatability of Liver Fat Quantification Using Confounder-corrected Chemical Shift-encoded MR Imaging. Magn Reson Med Sci 2017;16:332-9. [PMID: 28190853 DOI: 10.2463/mrms.mp.2016-0081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
524 Xue LY, Jiang ZY, Fu TT, Wang QM, Zhu YL, Dai M, Wang WP, Yu JH, Ding H. Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis.Eur Radiol. 2020;30:2973-2983. [PMID: 31965257 DOI: 10.1007/s00330-019-06595-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
525 Wu SD, Ding H, Liu LL, Zhuang Y, Liu Y, Cheng LS, Wang SQ, Tseng YJ, Wang JY, Jiang W. Longitudinal monitoring of liver stiffness by acoustic radiation force impulse imaging in patients with chronic hepatitis B receiving entecavir. Clin Res Hepatol Gastroenterol 2018;42:227-36. [PMID: 29066092 DOI: 10.1016/j.clinre.2017.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
526 Ronot M, Asselah T, Paradis V, Michoux N, Dorvillius M, Baron G, Marcellin P, Van Beers BE, Vilgrain V. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology. 2010;256:135-142. [PMID: 20574090 DOI: 10.1148/radiol.10091295] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 8.8] [Reference Citation Analysis]
527 Calès P, Boursier J, de Lédinghen V, Halfon P, Bacq Y, Leroy V, Dib N, Oberti F, Sawadogo A, Rousselet M, Lunel F. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroentérologie Clinique et Biologique 2008;32:1050-60. [DOI: 10.1016/j.gcb.2008.09.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
528 De Robertis R, D’Onofrio M, Demozzi E, Crosara S, Canestrini S, Pozzi Mucelli R. Noninvasive diagnosis of cirrhosis: A review of different imaging modalities. World J Gastroenterol 2014; 20(23): 7231-7241 [PMID: 24966594 DOI: 10.3748/wjg.v20.i23.7231] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
529 Fryer E, Wang LM, Verrill C, Fleming K. How often do our liver core biopsies reach current definitions of adequacy? J Clin Pathol 2013;66:1087-9. [PMID: 23863218 DOI: 10.1136/jclinpath-2013-201440] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
530 Hackl NJ, Bersch C, Feick P, Antoni C, Franke A, Singer MV, Nakchbandi IA. Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C. Scand J Gastroenterol. 2010;45:349-356. [PMID: 20017652 DOI: 10.3109/00365520903490606] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
531 Ehling J, Bartneck M, Wei X, Gremse F, Fech V, Möckel D, Baeck C, Hittatiya K, Eulberg D, Luedde T, Kiessling F, Trautwein C, Lammers T, Tacke F. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 2014;63:1960-71. [PMID: 24561613 DOI: 10.1136/gutjnl-2013-306294] [Cited by in Crossref: 152] [Cited by in F6Publishing: 146] [Article Influence: 21.7] [Reference Citation Analysis]
532 Poynard T, Imbert-bismut F, Munteanu M, Messous D, Thabut D, Ratziu V, Benhamou Y. Biomarkers as non-invasive assessment of hepatic fibrosis in chronic hepatitis C. J Gastroenterol Hepatol 2004;19:S236-45. [DOI: 10.1111/j.1440-1746.2004.03680.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
533 Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360-369. [PMID: 17439526 DOI: 10.1111/j.1365-2893.2006.00811.x] [Cited by in Crossref: 461] [Cited by in F6Publishing: 435] [Article Influence: 32.9] [Reference Citation Analysis]
534 Ho MC, Lin JJ, Shu YC, Chen CN, Chang KJ, Chang CC, Tsui PH. Using ultrasound Nakagami imaging to assess liver fibrosis in rats. Ultrasonics 2012;52:215-22. [PMID: 21907377 DOI: 10.1016/j.ultras.2011.08.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
535 Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol. 2007;7:40. [PMID: 17937811 DOI: 10.1186/1471-230x-7-40] [Cited by in Crossref: 205] [Cited by in F6Publishing: 75] [Article Influence: 14.6] [Reference Citation Analysis]
536 Chung YE, Park MS, Kim MS, Kim E, Park J, Song HT, Choi JY, Kim MJ, Kim KW. Quantification of superparamagnetic iron oxide-mediated signal intensity change in patients with liver cirrhosis using T2 and T2* mapping: a preliminary report. J Magn Reson Imaging 2010;31:1379-86. [PMID: 20512890 DOI: 10.1002/jmri.22184] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
537 Masuzaki R, Tateishi R, Yoshida H, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Asaoka Y, Kondo Y, Goto T, Ikeda H, Shiina S, Omata M, Koike K. Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastography. World J Gastroenterol 2012; 18(12): 1385-1390 [PMID: 22493553 DOI: 10.3748/wjg.v18.i12.1385] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
538 Bedossa P, Garcia-Tsao G, Jain D. Cirrhosis Regression and Subclassification. Surg Pathol Clin 2013;6:295-309. [PMID: 26838976 DOI: 10.1016/j.path.2013.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
539 Arima Y, Kawabe N, Hashimoto S, Harata M, Nitta Y, Murao M, Nakano T, Shimazaki H, Kobayashi K, Ichino N, Osakabe K, Nishikawa T, Okumura A, Ishikawa T, Yoshioka K. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. Hepatol Res 2010;40:383-92. [PMID: 20236358 DOI: 10.1111/j.1872-034X.2009.00618.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
540 Almasio PL, Niero M, Angioli D, Ascione A, Gullini S, Minoli G, Oprandi NC, Pinzello GB, Verme G, Andriulli A. Experts’ opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.). J Hepatol. 2005;43:381-387. [PMID: 16006002 DOI: 10.1016/j.jhep.2005.02.041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
541 Chan HL, Wong VW. Hepatitis B. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 540-63. [DOI: 10.1016/b978-1-4377-0881-3.00030-9] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
542 Coral GP, Antunes AD, Serafini AP, Araujo FB, Mattos AA. LIVER BIOPSY: IMPORTANCE OF SPECIMEN SIZE IN THE DIAGNOSIS AND STAGING OF CHRONIC VIRAL HEPATITIS. Rev Inst Med Trop Sao Paulo 2016;58:10. [PMID: 26910447 DOI: 10.1590/S1678-9946201658010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
543 Caillot F, Hiron M, Goria O, Gueudin M, Francois A, Scotte M, Daveau M, Salier JP. Novel serum markers of fibrosis progression for the follow-up of hepatitis C virus-infected patients. Am J Pathol 2009;175:46-53. [PMID: 19477948 DOI: 10.2353/ajpath.2009.080850] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
544 França M, Martí-Bonmatí L, Alberich-Bayarri Á, Oliveira P, Guimaraes S, Oliveira J, Amorim J, Gonzalez JS, Vizcaíno JR, Miranda HP. Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging. Abdom Radiol (NY) 2017;42:468-77. [PMID: 27638516 DOI: 10.1007/s00261-016-0899-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
545 Morisaka H, Motosugi U, Ichikawa S, Nakazawa T, Kondo T, Funayama S, Matsuda M, Ichikawa T, Onishi H. Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging. J Magn Reson Imaging 2018;47:1268-75. [PMID: 29030995 DOI: 10.1002/jmri.25868] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
546 Manning DS, Afdhal NH. EUS-guided liver biopsy: a procedure looking for an indication. Gastrointestinal Endoscopy 2009;69:543-5. [DOI: 10.1016/j.gie.2008.11.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
547 Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, Kianmanesh R, Ng IO, Curley SA, Yamaoka Y. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005;137:403-410. [PMID: 15800485 DOI: 10.1016/j.surg.2004.12.012] [Cited by in Crossref: 161] [Cited by in F6Publishing: 155] [Article Influence: 10.1] [Reference Citation Analysis]
548 Hu X, Shao J, Bai J, Wang J, Qian L. New noninvasive assessment of liver fibrosis in chronic hepatitis B: maximal accumulative respiration strain. J Ultrasound Med 2010;29:1213-21. [PMID: 20660455 DOI: 10.7863/jum.2010.29.8.1213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
549 Forns X. Diagnosis of liver fibrosis in 2008. Gastroentérologie Clinique et Biologique 2008;32:1-3. [DOI: 10.1016/s0399-8320(08)73988-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
550 Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol. 2010;26:227-233. [PMID: 20179592 DOI: 10.1097/MOG.0b013e3283383c68] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
551 Cross TJS, Calvaruso V, Foxton MR, Manousou P, Quaglia A, Grillo F, Dhillon AP, Nolan J, Chang TP, O’grady J, Heneghan MA, O’beirne JP, Burroughs AK, Harrison PM. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation: Noninvasive test for hepatitis C-related fibrosis post-LT. Journal of Viral Hepatitis 2010;17:640-9. [DOI: 10.1111/j.1365-2893.2009.01222.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
552 Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. Int J Hepatol. 2015;2015:852968. [PMID: 26693356 DOI: 10.1155/2015/852968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
553 Charlotte F, Le Naour G, Bernhardt C, Poynard T, Ratziu V. A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C. Hum Pathol. 2010;41:1178-1185. [PMID: 20413144 DOI: 10.1016/j.humpath.2009.10.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
554 Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, Seitz HK, Mueller S. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48:1718-23. [DOI: 10.1002/hep.22577] [Cited by in Crossref: 405] [Cited by in F6Publishing: 367] [Article Influence: 31.2] [Reference Citation Analysis]
555 Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS, Peterson M, Loomba R, Sirlin CB. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416-25. [PMID: 25247408 DOI: 10.1148/radiol.14140754] [Cited by in Crossref: 131] [Cited by in F6Publishing: 117] [Article Influence: 18.7] [Reference Citation Analysis]
556 Chotiyaputta W, Lok ASF. Endpoints of hepatitis B treatment: Endpoints of HBV treatment. Journal of Viral Hepatitis 2010;17:675-84. [DOI: 10.1111/j.1365-2893.2010.01369.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
557 Xu MY, Jia XF, Qu Y, Zheng RD, Yuan ZH, Weng HL, Dooley S, Wang XP, Zhang LJ, Lu LG. Serum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B. J Transl Med. 2013;11:234. [PMID: 24289155 DOI: 10.1186/1479-5876-11-234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
558 Mitchell DG, Navarro VJ, Herrine SK, Bergin D, Parker L, Frangos A, Mccue P, Rubin R. Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and staging. Abdom Imaging 2008;33:58-64. [DOI: 10.1007/s00261-007-9203-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
559 Nojiri S, Fujiwara K, Shinkai N, Endo M, Joh T. Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI. World J Hepatol 2014; 6(12): 930-938 [PMID: 25544880 DOI: 10.4254/wjh.v6.i12.930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
560 Orasan OH, Iancu M, Sava M, Saplontai-Pop A, Cozma A, Sarlea ST, Lungoci C, Ungureanu MI, Negrean V, Sampelean D, Dumitrascu DL. Non-invasive assessment of liver fibrosis in chronic viral hepatitis. Eur J Clin Invest 2015;45:1243-51. [PMID: 26426402 DOI: 10.1111/eci.12543] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
561 Sandberg JK, Sun Y, Ju Z, Liu S, Jiang J, Koci M, Rosenberg J, Rubesova E, Barth RA. Ultrasound shear wave elastography: does it add value to gray-scale ultrasound imaging in differentiating biliary atresia from other causes of neonatal jaundice? Pediatr Radiol 2021;51:1654-66. [PMID: 33772640 DOI: 10.1007/s00247-021-05024-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
562 Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology. 2007;45:1056-1075. [PMID: 17393513 DOI: 10.1002/hep.21627] [Cited by in Crossref: 407] [Cited by in F6Publishing: 373] [Article Influence: 29.1] [Reference Citation Analysis]
563 Liu GJ, Ji Q, Moriyasu F, Xie XY, Wang W, Wong LH, Lin MX, Lu MD. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats. Ultrasound Med Biol. 2013;39:2158-2165. [PMID: 23969165 DOI: 10.1016/j.ultrasmedbio.2013.05.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
564 Bedossa P, Patel K, Castera L. Histologic and noninvasive estimates of liver fibrosis. Clin Liver Dis (Hoboken). 2015;6:5-8. [PMID: 31040975 DOI: 10.1002/cld.481] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
565 Leporq B, Ratiney H, Pilleul F, Beuf O. Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T. Eur Radiol 2013;23:2175-86. [PMID: 23588583 DOI: 10.1007/s00330-013-2826-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
566 Miele L, Forgione A, Gasbarrini G, Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl Res. 2007;149:114-125. [PMID: 17320797 DOI: 10.1016/j.trsl.2006.11.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
567 Macaluso FS, Maida M, Cammà C, Cabibbo G, Cabibi D, Alduino R, Di Marco V, Craxì A, Petta S. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. J Hepatol. 2014;61:523-529. [PMID: 24815874 DOI: 10.1016/j.jhep.2014.04.045] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
568 Kamphues C, Lotz K, Röcken C, Berg T, Eurich D, Pratschke J, Neuhaus P, Neumann UP. Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients. Clin Transplant. 2010;24:652-659. [PMID: 19925459 DOI: 10.1111/j.1399-0012.2009.01152.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
569 Simpson KE, Esmaeeli A, Khanna G, White F, Turnmelle Y, Eghtesady P, Boston U, Canter CE. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant 2014;33:170-7. [PMID: 24365764 DOI: 10.1016/j.healun.2013.10.033] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
570 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Reference Citation Analysis]
571 Schiavon LL, Narciso-Schiavon JL, Carvalho Filho RJ, Sampaio JP, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. J Viral Hepat 2008;15:666-74. [PMID: 18482283 DOI: 10.1111/j.1365-2893.2008.00992.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
572 Lin Z, Liang J, Zhu J, Hu C, Gu Y, Lai J, Zheng Y, Gao Z. Diverse correlations between fibrosis-related factors and liver stiffness measurement by transient elastography in chronic hepatitis B. Eur J Gastroenterol Hepatol 2018;30:217-25. [PMID: 29194232 DOI: 10.1097/MEG.0000000000001023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
573 Lawson A, Hagan S, Rye K, Taguri N, Ratib S, Zaitoun AM, Neal KR, Ryder SD, Irving WL. The natural history of hepatitis C with severe hepatic fibrosis. J Hepatol. 2007;47:37-45. [PMID: 17400322 DOI: 10.1016/j.jhep.2007.02.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
574 Thuluvath PJ, Krok KL. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time. Am J Gastroenterol. 2005;100:1981-1983. [PMID: 16128942 DOI: 10.1111/j.1572-0241.2005.00284.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
575 Chen H, Zhou L, Liao B, Cao Q, Jiang H, Zhou W, Wang G, Xie X. Two-Dimensional Shear Wave Elastography Predicts Liver Fibrosis in Jaundiced Infants with Suspected Biliary Atresia: A Prospective Study. Korean J Radiol 2021;22:959-69. [PMID: 33569934 DOI: 10.3348/kjr.2020.0885] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
576 Hu X, Xu X, Zhang Q, Zhang H, Liu J, Qian L. Indirect prediction of liver fibrosis by quantitative measurement of spleen stiffness using the FibroScan system. J Ultrasound Med 2014;33:73-81. [PMID: 24371101 DOI: 10.7863/ultra.33.1.73] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
577 Świderska M, Jaroszewicz J, Parfieniuk-Kowerda A, Rogalska-Płońska M, Stawicka A, Panasiuk A, Flisiak R. Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease. Mediators Inflamm 2017;2017:3480234. [PMID: 28827897 DOI: 10.1155/2017/3480234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
578 Calès P, Lainé F, Boursier J, Deugnier Y, Moal V, Oberti F, Hunault G, Rousselet MC, Hubert I, Laafi J. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol. 2009;50:165-173. [PMID: 18977552 DOI: 10.1016/j.jhep.2008.07.035] [Cited by in Crossref: 170] [Cited by in F6Publishing: 139] [Article Influence: 13.1] [Reference Citation Analysis]
579 Mummadi RR, Petersen JR, Xiao SY, Snyder N. Role of simple biomarkers in predicting fibrosis progression in HCV infection. World J Gastroenterol 2010; 16(45): 5710-5715 [PMID: 21128320 DOI: 10.3748/wjg.v16.i45.5710] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
580 Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009;50:1294-1306. [PMID: 19711424 DOI: 10.1002/hep.23123] [Cited by in Crossref: 214] [Cited by in F6Publishing: 222] [Article Influence: 17.8] [Reference Citation Analysis]
581 Liu C, Lin J, Tsai F, Yang P, Lai M, Chen J, Kao J, Chen D. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 2006;26:1087-94. [DOI: 10.1111/j.1478-3231.2006.01355.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
582 Macías J, Mira J, Gilabert I, Neukam K, Roldán C, Viloria M, Moro A, Pineda JA. Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med 2011;12:14-21. [PMID: 20497249 DOI: 10.1111/j.1468-1293.2010.00836.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
583 Berenguer J, Zamora FX, Aldámiz-echevarría T, Von Wichmann MA, Crespo M, López-aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-pellicer J, Esteban H, Bellón JM, González-garcía J, Miralles P, Cosín J, López J, Padilla B, Parras F, Carrero A, Aldamiz-echevarría T, Tejerina F, Gutiérrez I, Ramírez M, Carretero S, Bellón J, Berenguer J, Alvarez-pellicer J, Rodríguez E, Arribas J, Montes M, Bernardino I, Pascual J, Zamora F, Peña J, Arnalich F, Díaz M, González-garcía J, Bustinduy M, Iribarren J, Rodríguez-arrondo F, Von-wichmann M, Blanes M, Cuellar S, Lacruz J, Montero M, Salavert M, López-aldeguer J, Callau P, Miró J, Gatell J, Mallolas J, Ferrer A, Galindo M, Van den Eynde E, Pérez M, Ribera E, Crespo M, Vergas J, Téllez M, Casado J, Dronda F, Moreno A, Pérez-elías M, Sanfrutos M, Moreno S, Quereda C, Jou A, Tural C, Arranz A, Casas E, de Miguel J, Schroeder S, Sanz J, Condés E, Barros C, Sanz J, Santos I, Hernando A, Rodríguez V, Rubio R, Pulido F, Domingo P, Guardiola J, Ortiz L, Ortega E, Torres R, Cervero M, Jusdado J, Rodríguez-zapata M, Pérez G, Gaspar G, Barquilla E, Ramírez M, Moyano B, Aznar E, Esteban H; for the Grupo de Estudio del SIDA (GESIDA) HIV/HCV Cohort Study Group. Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus. Clinical Infectious Diseases 2015;60:950-8. [DOI: 10.1093/cid/ciu939] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
584 Hendrie JD, Blumer MC, Fenton HH, Abrams GA. Two Fatty Liver Conditions Masquerading as Autoimmune Hepatitis. Case Reports Hepatol 2021;2021:8820350. [PMID: 33763269 DOI: 10.1155/2021/8820350] [Reference Citation Analysis]
585 Shin WG, Park SH, Jun SY, Jung JO, Moon JH, Kim JP, Kim KO, Park CH, Hahn TH, Yoo KS, Kim JH, Park CK. Simple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases. Gut Liver 2007;1:145-50. [PMID: 20485631 DOI: 10.5009/gnl.2007.1.2.145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
586 Feld JJ, Wong DK, Heathcote EJ. Endpoints of therapy in chronic hepatitis B. Hepatology 2009;49:S96-S102. [PMID: 19399800 DOI: 10.1002/hep.22977] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
587 de Franchis R, Dell’Era A. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol. 2007;21:3-18. [PMID: 17223493 DOI: 10.1016/j.bpg.2006.07.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
588 Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med. 2010;2:49-67. [PMID: 24367208 DOI: 10.2147/hmer.s7394] [Cited by in Crossref: 196] [Cited by in F6Publishing: 81] [Article Influence: 17.8] [Reference Citation Analysis]
589 Halfon P, Bourlière M, Pénaranda G, Cacoub P. [Serum markers of non-invasive fibrosis in chronic hepatitis C virus infection]. Rev Med Interne 2006;27:751-61. [PMID: 16815598 DOI: 10.1016/j.revmed.2006.03.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
590 Qi M, Chen Y, Zhang GQ, Meng YJ, Zhao FL, Wang J, Ma J. Clinical significance of preoperative liver stiffness measurements in primary HBV-positive hepatocellular carcinoma. Future Oncol 2017;13:2799-810. [PMID: 29189041 DOI: 10.2217/fon-2017-0281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
591 Guha I, Rosenberg W. Noninvasive Assessment of Liver Fibrosis: Serum Markers, Imaging, and Other Modalities. Clinics in Liver Disease 2008;12:883-900. [DOI: 10.1016/j.cld.2008.07.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
592 Lucidarme D, Foucher J, Le Bail B, Vergniol J, Castera L, Duburque C, Forzy G, Filoche B, Couzigou P, de Lédinghen V. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology. 2009;49:1083-1089. [PMID: 19140221 DOI: 10.1002/hep.22748] [Cited by in Crossref: 160] [Cited by in F6Publishing: 163] [Article Influence: 13.3] [Reference Citation Analysis]
593 Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, Goldin R, Njai HF, Ndow G, Taal M, Cooke G, D'Alessandro U, Vray M, Mbaye PS, Njie R, Mallet V, Thursz M. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65:1369-1376. [PMID: 26109530 DOI: 10.1136/gutjnl-2015-309260] [Cited by in Crossref: 165] [Cited by in F6Publishing: 160] [Article Influence: 27.5] [Reference Citation Analysis]
594 Parra M, Laufer N, Manrique JM, Jones LR, Quarleri J. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients. Biomed Res Int 2017;2017:1728456. [PMID: 29259976 DOI: 10.1155/2017/1728456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
595 Cholongitas E, Quaglia A, Samonakis D, Senzolo M, Triantos C, Patch D, Leandro G, Dhillon AP, Burroughs AK. Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut. 2006;55:1789-1794. [PMID: 16636018 DOI: 10.1136/gut.2005.090415] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 5.2] [Reference Citation Analysis]
596 Rockey DC. Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol. 2013;11:224-31.e1-5. [PMID: 23305825 DOI: 10.1016/j.cgh.2013.01.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
597 Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, Lebray P, Thibault V, Benhamou Y, Moussalli J. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem. 2006;52:1887-1896. [PMID: 16931569 DOI: 10.1373/clinchem.2006.070961] [Cited by in Crossref: 170] [Cited by in F6Publishing: 167] [Article Influence: 11.3] [Reference Citation Analysis]
598 Li F, Song Z, Li Q, Wu J, Wang J, Xie C, Tu C, Wang J, Huang X, Lu W. Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin αvβ3 expression with SPECT in rat. Hepatology 2011;54:1020-30. [PMID: 21618580 DOI: 10.1002/hep.24467] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
599 Rumi MG, De Filippi F, La Vecchia C, Donato MF, Gallus S, Del Ninno E, Colombo M. Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients. Gut. 2005;54:402-406. [PMID: 15710990 DOI: 10.1136/gut.2004.048009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
600 Verbeek J, Spincemaille P, Vanhorebeek I, Van den Berghe G, Vander Elst I, Windmolders P, van Pelt J, van der Merwe S, Bedossa P, Nevens F, Cammue B, Thevissen K, Cassiman D. Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. Lipids Health Dis. 2017;16:46. [PMID: 28231800 DOI: 10.1186/s12944-017-0432-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
601 Palacios Pérez Á, Salmerón Escobar J. Papel de la biopsia hepática en el diagnóstico y el control de la hepatitis C crónica. Gastroenterología y Hepatología 2007;30:402-7. [DOI: 10.1157/13108806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
602 Elkabbany ZA, Elbarbary NS, Ismail EA, Mohamed NA, Ragab D, Abdel Alem S, Ezzat YM, Maurice SS, Hashem NU. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus. J Diabetes Complications 2017;31:186-94. [PMID: 27742550 DOI: 10.1016/j.jdiacomp.2016.09.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
603 Della-guardia B, Evangelista AS, Felga GE, Marins LV, Salvalaggio PR, Almeida MD. Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed? Dig Dis Sci 2017;62:264-72. [DOI: 10.1007/s10620-016-4349-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
604 Ge F, Lobdell H 4th, Zhou S, Hu C, Berk PD. Digital analysis of hepatic sections in mice accurately quantitates triglycerides and selected properties of lipid droplets. Exp Biol Med (Maywood) 2010;235:1282-6. [PMID: 20975077 DOI: 10.1258/ebm.2010.010095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
605 White DL, Hashmi A, Ramsey DJ, Kuzniarek J, Tavakoli-tabasi S, El-serag HB. Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease. Dig Dis Sci 2012;57:3004-10. [DOI: 10.1007/s10620-012-2231-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
606 Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography. J Thromb Haemost. 2007;5:25-30. [PMID: 17239163 DOI: 10.1111/j.1538-7836.2006.02272.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
607 Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005;42:1373-1381. [PMID: 16317693 DOI: 10.1002/hep.20935] [Cited by in Crossref: 372] [Cited by in F6Publishing: 320] [Article Influence: 23.3] [Reference Citation Analysis]
608 Tosun M, Inan N, Sarisoy HT, Akansel G, Gumustas S, Gürbüz Y, Demirci A. Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol. 2013;82:203-207. [PMID: 23122674 DOI: 10.1016/j.ejrad.2012.09.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
609 Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis. 2008;40:371-378. [PMID: 18083083 DOI: 10.1016/j.dld.2007.10.019] [Cited by in Crossref: 282] [Cited by in F6Publishing: 254] [Article Influence: 20.1] [Reference Citation Analysis]
610 Osaki A, Kubota T, Suda T, Igarashi M, Nagasaki K, Tsuchiya A, Yano M, Tamura Y, Takamura M, Kawai H, Yamagiwa S, Kikuchi T, Nomoto M, Aoyagi Y. Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis. World J Gastroenterol 2010; 16(23): 2918-2925 [PMID: 20556839 DOI: 10.3748/wjg.v16.i23.2918] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
611 Stasi C, Arena U, Vizzutti F, Zignego AL, Monti M, Laffi G, Corti G, Pinzani M. Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool? Dig Liver Dis. 2009;41:863-866. [PMID: 19482565 DOI: 10.1016/j.dld.2009.04.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
612 Lu Q, Lu C, Li J, Ling W, Qi X, He D, Liu J, Wen T, Wu H, Zhu H, Luo Y. Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B. Radiology 2016;280:290-9. [PMID: 26885682 DOI: 10.1148/radiol.2016151229] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
613 McHutchison JG, Patel K, Schiff ER, Gitlin N, Mur RE, Everson GT, Carithers RL Jr, Davis GL, Marcellin P, Shiffman ML, Harvey J, Albrecht JK; International Hepatitis Interventional Therapy Group. Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C. Aliment Pharmacol Ther 2008;27:422-32. [PMID: 18081733 DOI: 10.1111/j.1365-2036.2007.03590.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
614 Su LN, Guo SL, Li BX, Yang P. Diagnostic value of magnetic resonance elastography for detecting and staging of hepatic fibrosis: a meta-analysis. Clin Radiol. 2014;69:e545-e552. [PMID: 25300557 DOI: 10.1016/j.crad.2014.09.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
615 Vergniol J, de Lédinghen V. HCV: Fibrosis Progression. Curr Hepatology Rep 2014;13:265-72. [DOI: 10.1007/s11901-014-0247-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
616 Lee KG, Seo YS, An H, Um SH, Jung ES, Keum B, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2010;25:94-100. [DOI: 10.1111/j.1440-1746.2009.05953.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
617 Plebani M, Basso D. Non-invasive assessment of chronic liver and gastric diseases. Clin Chim Acta. 2007;381:39-49. [PMID: 17374528 DOI: 10.1016/j.cca.2007.02.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
618 Bachtiar V, Kelly MD, Wilman HR, Jacobs J, Newbould R, Kelly CJ, Gyngell ML, Groves KE, McKay A, Herlihy AH, Fernandes CC, Halberstadt M, Maguire M, Jayaratne N, Linden S, Neubauer S, Banerjee R. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PLoS One. 2019;14:e0214921. [PMID: 30970039 DOI: 10.1371/journal.pone.0214921] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 17.5] [Reference Citation Analysis]
619 El-Kamary SS, Mohamed MM, El-Raziky M, Shardell MD, Shaker OG, ElAkel WA, Esmat G. Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection. Liver Int. 2013;33:982-990. [PMID: 23509874 DOI: 10.1111/liv.12139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
620 Crockett SD, Kaltenbach T, Keeffe EB. Do We Still Need a Liver Biopsy? Are the Serum Fibrosis Tests Ready for Prime Time? Clinics in Liver Disease 2006;10:513-34. [DOI: 10.1016/j.cld.2006.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
621 Bedossa P, Paradis V, Zucman-rossi J. Cellular and Molecular Techniques. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 88-110. [DOI: 10.1016/b978-0-7020-6697-9.00002-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
622 Searle J, Mendelson R, Zelesco M, Sanford J, Cheng W, McKinstry C, Ramsay D. Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study. J Med Imaging Radiat Oncol. 2008;52:130-133. [PMID: 18373803 DOI: 10.1111/j.1440-1673.2008.01930.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
623 Truant S, Baillet C, Gnemmi V, Fulbert M, Turpin A, Dardenne S, Leteurtre E, El Amrani M, Dharancy S, Dubuquoy L, Huglo D, Chesné C, Pruvot FR. The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy. Ann Surg Oncol 2021;28:1959-69. [PMID: 32833150 DOI: 10.1245/s10434-020-08988-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
624 Calvaruso V, Di Marco V, Bavetta MG, Cabibi D, Conte E, Bronte F, Simone F, Burroughs AK, Craxì A. Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis. Aliment Pharmacol Ther. 2015;41:477-486. [PMID: 25580867 DOI: 10.1111/apt.13051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
625 Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, Asselah T, Boyer N, Lada O, Castelnau C, Martinot-Peignoux M, Valla DC, Bedossa P, Marcellin P. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012;32:612-621. [PMID: 22103765 DOI: 10.1111/j.1478-3231.2011.02660.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 9.7] [Reference Citation Analysis]
626 Poynard T, Munteanu M, Deckmyn O, Ngo Y, Drane F, Messous D, Castille JM, Housset C, Ratziu V, Imbert-Bismut F. Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age. BMC Gastroenterol 2011;11:39. [PMID: 21492460 DOI: 10.1186/1471-230X-11-39] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
627 Mendes LC, Ferreira PA, Miotto N, Zanaga L, Gonçales E, Lazarini MS, Gonçales FL Júnior, Stucchi RS, Vigani AG. Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C. Braz J Med Biol Res 2016;49:e5432. [PMID: 27533769 DOI: 10.1590/1414-431X20165432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
628 Nasr A, Avitzur Y, Ng VL, De Silva N, Wales PW. The use of conjugated hyperbilirubinemia greater than 100 μmol/L as an indicator of irreversible liver disease in infants with short bowel syndrome. Journal of Pediatric Surgery 2007;42:359-62. [DOI: 10.1016/j.jpedsurg.2006.10.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
629 Schiavon LL, Schiavon JLN, Carvalho Filho RJ, Sampaio JP, Lanzoni VP, Silva AEB, Ferraz MLG. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection. Hepatology 2007;46:307-14. [DOI: 10.1002/hep.21681] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
630 Ahmad W, Ijaz B, Gull S, Asad S, Khaliq S, Jahan S, Sarwar MT, Kausar H, Sumrin A, Shahid I. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J. 2011;8:53. [PMID: 21299910 DOI: 10.1186/1743-422x-8-53] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
631 Igarashi H, Shigiyama F, Wakui N, Nagai H, Shibuya K, Shiraga N, Hirose T, Kumashiro N. Whole hepatic lipid volume quantification and color mapping by multi-slice and multi-point magnetic resonance imaging. Hepatol Res 2019;49:1374-85. [PMID: 31313870 DOI: 10.1111/hepr.13408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
632 Li BB, Li DL, Chen C, Liu BH, Xia CY, Wu HJ, Wu CQ, Ji GQ, Liu S, Ni W, Yao DK, Zeng ZY, Chen DG, Qin BD, Xin X, Yan GL, Dan Tang, Liu HM, He J, Yan H, Zhu WJ, Yu HY, Zhu L. Potentials of the elevated circulating miR-185 level as a biomarker for early diagnosis of HBV-related liver fibrosis. Sci Rep. 2016;6:34157. [PMID: 27677421 DOI: 10.1038/srep34157] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
633 Czaja AJ. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol 2014; 20(10): 2515-2532 [PMID: 24627588 DOI: 10.3748/wjg.v20.i10.2515] [Cited by in CrossRef: 190] [Cited by in F6Publishing: 176] [Article Influence: 27.1] [Reference Citation Analysis]
634 Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468-475. [PMID: 23234725 DOI: 10.1016/s0140-6736(12)61425-1] [Cited by in Crossref: 1004] [Cited by in F6Publishing: 401] [Article Influence: 111.6] [Reference Citation Analysis]
635 Palmeri ML, Wang MH, Dahl JJ, Frinkley KD, Nightingale KR. Quantifying hepatic shear modulus in vivo using acoustic radiation force. Ultrasound Med Biol 2008;34:546-58. [PMID: 18222031 DOI: 10.1016/j.ultrasmedbio.2007.10.009] [Cited by in Crossref: 478] [Cited by in F6Publishing: 325] [Article Influence: 36.8] [Reference Citation Analysis]
636 Liu T, Sun Y, Zhou J, Yang F, Zou X, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Wang T, Ou X, Wu S, Kong Y, Wang P, Cong M, Zhang Y, You H, Jia J. On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy. J Med Virol 2019;91:1499-509. [PMID: 30905065 DOI: 10.1002/jmv.25465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
637 Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 2011;4:391-417. [PMID: 22043231 DOI: 10.1177/1756283x11413002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 71] [Article Influence: 14.1] [Reference Citation Analysis]
638 Afdhal NH, Bacon BR, Patel K, Lawitz EJ, Gordon SC, Nelson DR, Challies TL, Nasser I, Garg J, Wei LJ. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol. 2015;13:772-9.e1-3. [PMID: 25528010 DOI: 10.1016/j.cgh.2014.12.014] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 14.7] [Reference Citation Analysis]
639 Bruce M, Kolokythas O, Ferraioli G, Filice C, O'Donnell M. Limitations and artifacts in shear-wave elastography of the liver. Biomed Eng Lett 2017;7:81-9. [PMID: 30603154 DOI: 10.1007/s13534-017-0028-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
640 Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008;40:267-274. [PMID: 18055281 DOI: 10.1016/j.dld.2007.10.011] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 7.1] [Reference Citation Analysis]
641 Jiang W, Huang S, Teng H, Wang P, Wu M, Zhou X, Ran H. Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis. BMJ Open 2018;8:e021787. [PMID: 30139901 DOI: 10.1136/bmjopen-2018-021787] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
642 闫雪华, 陈小勇, 李斌华, 李佳栗, 马媛芝. 长期有效的抗病毒治疗对慢性乙型肝炎肝纤维化的影响. 世界华人消化杂志 2014; 22(20): 2933-2936 [DOI: 10.11569/wcjd.v22.i20.2933] [Reference Citation Analysis]
643 Tyson GL, Richardson PA, White DL, Kuzniarek J, Ramsey DJ, Tavakoli-Tabasi S, El-Serag HB. Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients. J Clin Gastroenterol 2013;47:545-52. [PMID: 23426443 DOI: 10.1097/MCG.0b013e31827244d9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
644 Ahmed Y, Hussein RS, Basha TA, Khalifa AM, Ibrahim AS, Abdelmoaty AS, Abdella HM, Fahmy AS. Detecting liver fibrosis using a machine learning-based approach to the quantification of the heart-induced deformation in tagged MR images. NMR Biomed. 2020;33:e4215. [PMID: 31730265 DOI: 10.1002/nbm.4215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
645 Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, Bernstien D, Maruyama H, Saraswat V, Chawla Y, Hamid S, Abbas Z, Bedossa P, Sakhuja P, Elmahatab M, Lim SG, Lesmana L, Sollano J, Jia JD, Abbas B, Omar A, Sharma B, Payawal D, Abdallah A, Serwah A, Hamed A, Elsayed A, AbdelMaqsod A, Hassanein T, Ihab A, GHaziuan H, Zein N, Kumar M. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11:1-30. [PMID: 27714681 DOI: 10.1007/s12072-016-9760-3] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 18.6] [Reference Citation Analysis]
646 . Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney International 2008;73:S53-68. [DOI: 10.1038/ki.2008.87] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
647 Sheela H, Seela S, Caldwell C, Boyer JL, Jain D. Liver Biopsy: Evolving Role in the New Millennium. Journal of Clinical Gastroenterology 2005;39:603-10. [DOI: 10.1097/01.mcg.0000170742.59134.60] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
648 Poynard T, Ratziu V, Kim N, Deuffic-Burban S. Age and gender will survive to competing risks as fibrosis factors. Gastroenterology 2005;128:519-20; author reply 520-1. [PMID: 15685574 DOI: 10.1053/j.gastro.2004.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
649 Malaguarnera G, Cataudella E, Giordano M, Nunnari G, Chisari G, Malaguarnera M. Toxic hepatitis in occupational exposure to solvents. World J Gastroenterol 2012; 18(22): 2756-2766 [PMID: 22719183 DOI: 10.3748/wjg.v18.i22.2756] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 58] [Article Influence: 8.9] [Reference Citation Analysis]
650 Lazzarini AL, Levine RA, Ploutz-Snyder RJ, Sanderson SO. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int. 2005;25:1142-1149. [PMID: 16343064 DOI: 10.1111/j.1478-3231.2005.01155.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
651 Fontana RJ, Kleiner DE, Bilonick R, Terrault N, Afdhal N, Belle SH, Jeffers LJ, Ramcharran D, Ghany MG, Hoofnagle JH; Virahep-C Study Group. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology 2006;44:925-35. [DOI: 10.1002/hep.21335] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
652 Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, Voelker M, Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 2006; 12(21): 3338-3343 [PMID: 16733849 DOI: 10.3748/wjg.v12.i21.3338] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
653 Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future. World J Gastroenterol 2014; 20(31): 10851-10863 [PMID: 25152587 DOI: 10.3748/wjg.v20.i31.10851] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 59] [Article Influence: 9.7] [Reference Citation Analysis]
654 Focà E, Fabbiani M, Prosperi M, Quiros Roldan E, Castelli F, Maggiolo F, Di Filippo E, Di Giambenedetto S, Gagliardini R, Saracino A, Di Pietro M, Gori A, Sighinolfi L, Pan A, Postorino MC, Torti C; Italian MASTER Cohort. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study. Medicine (Baltimore) 2016;95:e4091. [PMID: 27442636 DOI: 10.1097/MD.0000000000004091] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
655 Hoodeshenas S, Yin M, Venkatesh SK. Magnetic Resonance Elastography of Liver: Current Update. Top Magn Reson Imaging. 2018;27:319-333. [PMID: 30289828 DOI: 10.1097/rmr.0000000000000177] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 19.5] [Reference Citation Analysis]
656 Ishibashi H, Maruyama H, Takahashi M, Fujiwara K, Imazeki F, Yokosuka O. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography. Liver Int. 2010;30:1355-1363. [PMID: 20704652 DOI: 10.1111/j.1478-3231.2010.02315.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
657 Goetz M, Deris I, Vieth M, Murr E, Hoffman A, Delaney P, Galle PR, Neurath MF, Kiesslich R. Near-infrared confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with increased imaging plane depth. J Hepatol 2010;53:84-90. [PMID: 20452700 DOI: 10.1016/j.jhep.2010.01.039] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
658 Chang PE, Hartono JL, Ngai YL, Dan YY, Lim KB, Chow WC. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore. Singapore Med J 2019;60:532-7. [PMID: 30556091 DOI: 10.11622/smedj.2018156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
659 Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42 Suppl:S22-S36. [PMID: 15777570 DOI: